Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3020717	p-zn	umol/l (umol/l)	1737	2757	0.07%
3020717	b-zn	umol/l (umol/l)	346	420	0.00%	Distribution not available
3020717	p-zn	— (—)	161	198	100.00%	Distribution not available
3020717	b-zn	— (—)	6	6	100.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Dermatitis

419

1050

4.03

147.31

1.4

1.5

20.11

27.06

umol/l

4.91

402

989

Dermatitis and eczema

681

1447

3.11

143.41

1.4

1.6

21.56

25.99

umol/l

3.15

658

1368

Other and unspecified dermatitis

359

857

4.23

134.89

1.4

1.5

19.27

26.99

umol/l

5.40

346

805

Anaemias

249

248

6.78

131.55

2.0

1.5

16.56

25.78

umol/l

4.20

240

243

Any gastric operation

482

747

3.26

99.77

1.8

1.3

20.25

28.39

umol/l

6.06

469

704

GASTRO-related operations

482

747

3.26

99.77

1.8

1.3

20.25

28.39

umol/l

6.06

469

704

Autoimmune diseases excluding thyroid diseases, strict definition

555

1104

2.82

94.30

1.7

1.5

19.42

26.50

umol/l

6.17

520

1061

Diseases of the skin and subcutaneous tissue

536

921

2.93

94.18

1.5

1.6

21.05

28.85

umol/l

5.98

514

869

Autoimmune diseases excluding thyroid diseases

568

1148

2.76

93.03

1.7

1.5

19.53

26.69

umol/l

6.36

533

1101

Examination and observation for other reasons

333

539

3.78

91.64

1.7

1.3

20.28

29.18

umol/l

4.94

317

510

ILD medications: immunosuppressive drugs

378

1161

3.15

90.70

1.7

1.5

17.02

26.70

umol/l

10.69

364

1108

ILD medications

624

1344

2.56

88.51

1.6

1.5

22.09

25.87

umol/l

2.16

596

1279

Autoimmune diseases

588

1158

2.61

84.28

1.7

1.5

20.97

26.62

umol/l

4.08

558

1111

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

530

1467

2.60

83.88

1.8

1.4

20.10

26.55

umol/l

5.39

509

1391

ILD medications: prednisolone, methylprednisolone, prednisone

586

1309

2.54

82.70

1.7

1.5

22.97

26.14

umol/l

1.49

557

1245

Used for control exclusion in common control thyroid runs

552

1063

2.64

81.24

1.6

1.5

21.15

26.37

umol/l

3.35

523

1022

Disorders of skin appendages

316

981

3.25

80.76

1.3

1.6

20.62

26.68

umol/l

3.34

301

940

Autoimmune diseases related-to ILD

466

1554

2.65

80.50

1.6

1.5

20.81

26.15

umol/l

3.59

444

1478

First line medication for Crohn's disease

601

1328

2.48

79.89

1.6

1.5

23.96

24.47

umol/l

0.14

578

1262

Obesity, other/unspecified

244

664

3.71

76.70

1.9

1.4

14.79

27.67

umol/l

13.92

237

635

Other disorders of skin and subcutaneous tissue

359

1126

2.94

75.96

1.5

1.4

20.42

26.30

umol/l

3.24

340

1065

Endocrine, nutritional and metabolic diseases

476

885

2.75

75.41

2.0

1.3

21.87

27.88

umol/l

3.57

457

846

Intestinal stricture

194

455

4.31

74.91

2.9

1.4

16.86

24.11

umol/l

3.25

187

434

Other nutritional deficiencies

382

1344

2.80

74.83

1.8

1.4

16.45

27.38

umol/l

14.50

366

1279

General symptoms and signs

571

1153

2.49

74.72

1.6

1.5

23.88

25.15

umol/l

0.39

547

1090

Dental caries

184

415

4.44

73.59

1.9

1.7

16.78

27.91

umol/l

6.36

179

403

Persons encountering health services for specific procedures and health care

577

1509

2.38

73.03

1.8

1.5

22.83

25.14

umol/l

0.99

560

1428

Anxiety disorders, excluding more controls

461

1170

2.63

72.80

1.7

1.4

21.13

28.20

umol/l

5.35

437

1115

Noninfective enteritis and colitis

294

944

3.14

70.99

2.1

1.5

22.20

25.10

umol/l

0.90

278

905

Neurotic, stress-related and somatoform disorders

497

1443

2.46

70.14

1.7

1.5

20.33

26.42

umol/l

4.95

472

1373

Medical observation and evaluation for suspected diseases and conditions

340

544

3.22

69.96

1.8

1.3

23.88

29.05

umol/l

1.76

317

514

General examination and investigation of persons without complaint and reported diagnosis

330

544

3.24

69.81

1.7

1.3

23.84

29.05

umol/l

1.76

309

514

Anxiety disorders

497

1453

2.44

68.63

1.7

1.5

20.47

26.37

umol/l

4.66

472

1382

Complications of medical and surgical care

377

1343

2.68

67.77

1.9

1.4

19.07

26.95

umol/l

6.29

358

1275

Inflammatory bowel disease treatment related agents

586

1450

2.31

67.62

1.6

1.5

22.14

25.62

umol/l

1.87

556

1381

Diseases of the digestive system

250

756

3.32

66.54

2.8

1.4

15.76

24.68

umol/l

7.40

239

723

Fever of other and unknown origin

279

831

3.13

66.19

2.0

1.4

23.34

25.74

umol/l

0.62

274

790

Other diseases of intestines

553

1405

2.30

63.79

1.8

1.5

23.16

24.92

umol/l

0.64

532

1340

Nutritional anaemias

259

799

3.18

63.63

1.9

1.5

15.36

25.38

umol/l

9.58

244

758

Paralytic ileus and intestinal obstruction

149

329

4.57

62.15

3.0

1.3

17.63

24.84

umol/l

2.38

144

312

Oral corticosteroids

518

1366

2.30

60.84

1.6

1.5

22.87

25.91

umol/l

1.33

491

1300

Other special examinations and investigations of persons without complaint or reported diagnosis

321

544

3.00

59.06

1.6

1.3

22.17

29.05

umol/l

2.88

306

514

Persons encountering health services for other counselling and medical advice, not elsewhere classified

544

1391

2.24

58.88

1.8

1.4

22.75

25.39

umol/l

1.17

526

1318

Obesity

342

1316

2.59

57.98

1.7

1.4

16.14

27.42

umol/l

14.78

331

1248

Obesity and other hyperalimentation

343

1321

2.59

57.95

1.7

1.4

16.13

27.49

umol/l

15.01

332

1253

Dentinal caries

153

365

4.21

57.43

1.9

1.7

14.97

27.58

umol/l

7.94

148

355

Gastrointestinal diseases

325

560

2.92

57.06

1.7

1.4

22.37

27.01

umol/l

1.67

314

529

Oedema, not elsewhere classified

168

436

3.86

56.14

1.6

1.4

16.43

25.64

umol/l

4.41

162

411

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

298

1102

2.71

55.43

2.0

1.4

17.04

26.63

umol/l

8.76

282

1051

Obesity due to excess calories

265

931

2.87

54.85

1.7

1.4

14.96

27.61

umol/l

15.80

257

891

Other septicaemia

187

526

3.51

54.22

2.4

1.4

15.41

25.61

umol/l

6.27

178

497

Tramadol

368

937

2.54

54.02

1.8

1.3

18.03

28.67

umol/l

10.20

353

886

Care involving use of rehabilitation procedures

321

1193

2.57

53.15

1.9

1.4

20.69

25.38

umol/l

2.24

315

1121

Other bacterial diseases

436

1314

2.30

53.11

1.9

1.4

18.56

26.79

umol/l

7.67

418

1243

Complications of surgical and medical care, not elsewhere classified

461

1482

2.24

53.08

1.9

1.4

19.59

26.68

umol/l

5.95

436

1408

Opioids

480

1123

2.25

51.59

1.7

1.4

23.14

27.69

umol/l

2.26

464

1062

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

279

1044

2.69

51.13

2.0

1.4

17.08

26.48

umol/l

7.97

264

995

Complications of procedures, not elsewhere classified

383

1418

2.34

51.12

2.0

1.4

19.83

26.83

umol/l

5.10

364

1349

Septicaemia

200

597

3.24

50.88

2.4

1.4

15.36

26.21

umol/l

7.56

191

563

Recurrent or chronic depression

235

556

3.07

50.63

1.5

1.4

22.12

28.73

umol/l

2.43

223

529

Chronic pancreatitis

167

5.72

50.52

2.2

1.3

21.77

25.69

umol/l

0.53

159

Other or unspecified ileus, impaction or obstruction

107

214

5.05

50.34

3.4

1.3

17.36

25.67

umol/l

2.20

102

203

Explicit Sepsis

212

677

3.02

47.88

2.4

1.5

15.96

25.61

umol/l

6.49

203

646

Second line medication for Crohn's disease

298

1192

2.51

47.75

1.6

1.5

18.12

26.33

umol/l

6.42

287

1135

Persons encountering health services in other circumstances, wide

548

1394

2.05

46.50

1.8

1.4

23.63

25.38

umol/l

0.62

526

1320

Other reaction to severe stress, and adjustment disorders

220

776

2.86

45.33

1.9

1.5

18.29

27.17

umol/l

5.53

209

747

L04AX Other immunosuppressants

287

1160

2.49

45.02

1.6

1.5

17.56

26.30

umol/l

7.25

277

1104

Any reimbursement code in KELA

320

627

2.57

44.76

1.8

1.3

23.34

26.37

umol/l

0.87

304

593

Mood disorders, excluding more controls

429

1202

2.18

44.58

1.7

1.4

19.65

28.13

umol/l

7.53

402

1145

Disorders of gallbladder, biliary tract and pancreas

439

1323

2.15

44.55

1.9

1.4

20.54

26.75

umol/l

4.34

420

1256

Persons encountering health services for examination and investigation

290

544

2.68

44.08

1.8

1.3

22.28

29.05

umol/l

2.67

276

514

Nausea and vomiting

157

453

3.44

44.07

2.2

1.6

20.88

25.84

umol/l

1.27

149

435

Other noninfective gastroenteritis and colitis

161

487

3.34

43.23

2.3

1.6

21.84

23.44

umol/l

0.27

151

465

Headache

308

1077

2.40

43.17

1.5

1.4

24.40

25.30

umol/l

0.19

293

1016

Depression

454

1511

2.08

43.04

1.6

1.5

19.21

26.60

umol/l

6.97

426

1442

Iron deficiency anaemia

205

708

2.89

43.04

1.7

1.5

16.61

25.51

umol/l

5.82

192

673

Mood [affective] disorders

473

1537

2.03

41.88

1.6

1.5

19.40

26.76

umol/l

7.01

444

1466

Codeine

424

1084

2.16

41.84

1.5

1.3

21.02

27.97

umol/l

4.67

408

1024

Hypothyroidism, strict autoimmune

314

868

2.40

41.79

1.5

1.4

23.47

27.99

umol/l

1.68

301

835

Mood disorders

473

1539

2.03

41.57

1.6

1.5

19.40

26.74

umol/l

6.98

444

1468

Oxycodone

149

425

3.41

41.30

2.0

1.3

27.46

27.56

umol/l

0.01

140

403

Malaise and fatigue

211

623

2.84

41.30

1.8

1.4

24.50

26.20

umol/l

0.31

203

588

Diseases of pulp and periapical tissues

170

550

3.11

40.88

1.7

1.5

17.93

28.37

umol/l

5.27

160

530

Other antidepressants

459

1155

2.08

40.80

1.6

1.5

22.13

26.83

umol/l

2.47

436

1103

Other and unspecified anaemias

179

577

3.02

40.58

1.8

1.4

17.89

24.78

umol/l

2.83

172

544

All anxiety disorders

320

1124

2.30

40.51

1.6

1.5

20.19

26.82

umol/l

4.17

306

1078

Other anaemias

181

587

2.99

40.38

1.8

1.4

17.79

24.87

umol/l

3.01

174

553

Symptoms and signs involving the digestive system and abdomen

444

1062

2.10

40.06

1.6

1.5

21.76

25.45

umol/l

1.68

422

1019

Aplastic and other anaemias

193

640

2.88

39.94

1.8

1.4

17.43

24.65

umol/l

3.41

185

604

Pain in joint

264

687

2.55

39.87

1.5

22.84

26.71

umol/l

1.18

251

651

Abdominal and pelvic pain

441

1058

2.10

39.86

1.6

1.5

22.15

25.50

umol/l

1.42

419

1015

Inflammatory bowel disease

185

639

2.92

39.70

1.9

1.5

21.08

25.33

umol/l

1.18

176

611

Crohn disease

105

252

4.22

39.64

2.3

1.5

16.28

24.49

umol/l

2.62

239

Atopic dermatitis

292

1067

2.35

39.10

1.6

1.7

21.43

26.33

umol/l

2.25

285

1016

Diseases of oesophagus, stomach and duodenum

471

1442

1.99

38.80

1.6

1.5

21.66

26.25

umol/l

2.64

442

1377

Benzodiazepine use

440

1568

2.00

38.28

1.6

1.5

22.24

25.80

umol/l

1.66

415

1493

Implicit bacterial Sepsis

159

466

3.15

38.22

1.8

1.4

14.33

25.89

umol/l

7.93

154

442

Renal failure

172

529

2.99

37.84

1.9

1.4

13.23

24.24

umol/l

9.90

164

504

Certain infectious and parasitic diseases

454

1121

2.03

37.72

1.6

1.5

23.37

26.24

umol/l

1.07

436

1066

Anxiety (asthma-related co-morbidities)

311

1089

2.26

37.67

1.6

1.5

20.11

27.64

umol/l

5.10

298

1047

Disorders of other endocrine glands

231

903

2.53

37.59

1.8

1.6

18.98

24.85

umol/l

2.85

225

863

Other and unspecified iron deficiency

165

557

2.98

36.90

1.7

1.4

17.88

25.16

umol/l

3.12

156

531

Intestinal infectious diseases

424

1664

1.99

36.90

1.9

1.5

22.02

24.67

umol/l

1.08

400

1585

Bacterial Sepsis

181

565

2.86

36.72

2.0

1.4

14.85

25.93

umol/l

7.92

176

536

Sleep disorders (combined)

429

1408

2.00

36.67

1.5

23.87

25.88

umol/l

0.64

401

1348

Atopic dermatitis, strict definition with reimbursement

191

677

2.76

36.67

1.7

21.69

24.47

umol/l

0.69

186

646

Other soft tissue disorders, not elsewhere classified

421

1287

2.03

36.65

1.5

22.70

24.95

umol/l

0.78

402

1230

Diarrhoea and gastroenteritis of presumed infectious origin

328

1395

2.14

35.96

2.0

1.5

21.08

24.79

umol/l

1.55

309

1334

Other diseases of hard tissues of teeth

290

947

2.29

35.84

1.7

1.5

20.28

27.84

umol/l

4.56

277

905

Metabolic disorders

407

1253

2.02

35.37

2.2

1.4

18.93

27.00

umol/l

7.24

391

1189

Other functional intestinal disorders

204

750

2.60

35.01

1.9

1.4

24.91

24.87

umol/l

0.01

196

711

Other anxiety disorders

239

877

2.43

34.93

1.6

1.5

21.10

27.11

umol/l

2.59

229

843

Neurological diseases

416

1040

2.02

34.05

1.7

1.5

21.43

26.63

umol/l

2.83

399

998

Episodal and paroxysmal disorders

502

1373

1.88

33.65

1.7

1.5

22.49

25.41

umol/l

1.29

481

1311

IBD patients in KELA-register

139

450

3.11

33.54

1.8

1.5

22.31

25.51

umol/l

0.60

132

428

Other disorders of fluid, electrolyte and acid-base balance

134

408

3.19

33.38

2.5

1.4

15.93

26.05

umol/l

4.55

127

387

Any mental disorder

473

1242

1.91

33.21

1.7

1.4

20.15

27.66

umol/l

6.42

447

1183

Psychiatric diseases

470

1232

1.92

33.18

1.7

1.4

20.44

27.67

umol/l

5.86

444

1175

Dorsalgia

437

1218

1.95

33.08

1.6

1.5

23.05

26.27

umol/l

1.32

417

1159

Chronic periapical parodontitis

106

292

3.66

33.03

1.6

1.5

16.86

29.15

umol/l

4.49

285

Bacterial infection, other or unspecified

206

739

2.53

32.90

2.3

1.4

19.73

26.99

umol/l

3.13

198

701

Hypothyroidism (congenital or acquired)

145

253

3.31

32.86

1.6

1.4

26.04

25.60

umol/l

0.05

138

247

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

391

1236

1.99

32.49

1.8

1.4

19.48

26.66

umol/l

5.38

373

1174

391

1236

1.99

32.49

1.8

1.4

19.48

26.66

umol/l

5.38

373

1174

Codeine or tramadol medication

480

1425

1.87

32.43

1.5

1.4

20.72

26.84

umol/l

4.46

462

1345

Depression medications

165

269

3.10

32.26

1.6

1.4

24.10

26.33

umol/l

0.35

156

262

Low back pain

316

1158

2.11

32.19

1.7

1.5

21.85

26.58

umol/l

2.08

302

1102

Mycoses

144

489

2.97

31.99

2.2

1.5

17.51

23.65

umol/l

2.24

136

469

Gastro-oesophageal reflux disease

283

1159

2.17

31.93

1.5

22.71

26.12

umol/l

1.10

261

1101

Abnormalities of breathing

408

1247

1.95

31.71

1.5

1.6

24.08

24.04

umol/l

0.01

382

1197

Asthma, excluding more controls

327

816

2.14

31.69

1.7

1.5

22.26

27.20

umol/l

2.04

313

776

Erysipelas

203

749

2.48

31.40

1.6

1.4

16.35

27.16

umol/l

7.15

196

703

Crohn's disease of large intestine

5.90

31.07

2.2

1.5

14.10

25.19

umol/l

2.57

Hypothyroidism and >3 levothyroxin purchases

141

253

3.22

30.73

1.5

1.4

27.13

25.60

umol/l

0.20

134

247

Hypothyroidism, levothyroxine purchases

141

253

3.22

30.73

1.5

1.4

27.13

25.60

umol/l

0.20

134

247

Irritable bowel syndrome

147

517

2.86

30.66

1.5

1.4

27.73

26.80

umol/l

0.12

139

489

Diseases of oral cavity, salivary glands and jaws

381

980

2.00

30.61

1.6

1.5

20.20

27.66

umol/l

5.18

363

934

Depression or dysthymia

289

739

2.20

30.15

1.7

1.4

19.35

28.19

umol/l

5.46

269

701

Asthma

330

852

2.08

29.92

1.7

1.5

22.15

26.78

umol/l

1.87

316

808

Implicit Sepsis

282

1031

2.13

29.71

1.8

1.4

17.03

26.58

umol/l

8.49

270

977

Inflammatory bowel disease, strict (require KELA)

139

483

2.90

29.68

1.8

1.5

22.31

25.53

umol/l

0.62

132

460

Dentofacial anomalies [including malocclusion]

149

533

2.78

29.44

1.7

1.5

23.28

28.69

umol/l

1.32

143

517

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

179

323

2.79

29.43

1.6

23.64

27.95

umol/l

0.90

172

312

Asthma (mode)

325

866

2.07

29.08

1.7

1.5

22.51

26.50

umol/l

1.46

310

822

Other pulmonary diagnosis

347

857

2.03

29.01

1.5

24.24

26.71

umol/l

0.70

332

812

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

414

1517

1.86

28.90

1.9

1.5

21.37

25.18

umol/l

1.88

393

1448

Condition for Implicit Sepsis (Organ dysfunction codes)

335

1233

1.98

28.52

1.7

1.4

18.32

26.68

umol/l

6.97

317

1171

Lower back pain or/and sciatica

421

1596

1.83

28.29

1.6

1.4

21.11

25.93

umol/l

2.89

400

1516

Constipation

352

1306

1.94

28.05

1.5

21.43

25.81

umol/l

2.04

329

1247

Cystic fibrosis with pulmonary manifestations

+∞

27.89

3.5

0.0

13.14

—

umol/l

—

Other and unspecified polyneuropathies, also in other diseases

251

3.62

27.62

1.8

1.4

18.30

24.10

umol/l

1.12

241

5-aminosalicylic acid

119

396

3.03

27.47

1.9

1.5

23.05

25.06

umol/l

0.30

112

382

Influenza and pneumonia

451

1665

1.79

27.47

1.8

1.5

19.43

25.92

umol/l

5.49

429

1586

Asthma (only as main-diagnosis), excluding more controls

287

816

2.10

27.41

1.7

1.5

22.69

27.20

umol/l

1.62

275

776

Other dorsopathies, not elsewhere classified

428

1232

1.84

27.17

1.6

1.5

22.87

26.18

umol/l

1.37

410

1173

Ulcerative colitis

130

458

2.86

27.10

1.9

1.5

23.56

24.70

umol/l

0.16

124

437

Excluding asthma or asthma-COPD overlap

340

857

1.99

26.96

1.5

24.09

26.71

umol/l

0.75

326

812

Hypothyroidism, other/unspecified

379

1344

1.87

26.65

1.5

24.93

24.70

umol/l

0.05

363

1283

Pain in limb

328

1224

1.94

26.54

1.6

1.5

20.67

25.18

umol/l

2.12

318

1170

Somatoform disorder

101

312

3.27

26.48

1.6

1.4

23.74

25.00

umol/l

0.15

299

Symptoms and signs involving the circulatory and respiratory systems

449

1255

1.80

26.28

1.6

26.33

23.98

umol/l

0.78

428

1205

Hypothyreosis and Thyroxine purchase for inclusion criteria

389

1401

1.84

26.06

1.5

24.98

24.97

umol/l

0.00

372

1335

Polyneuropathies and other disorders of the peripheral nervous system

300

3.29

26.05

1.8

1.5

17.60

24.31

umol/l

1.58

289

Cardiovascular diseases (excluding rheumatic etc)

339

1011

1.94

26.02

1.7

1.6

21.19

27.38

umol/l

3.42

326

964

Infections of the skin and subcutaneous tissue

253

1220

2.07

26.01

1.9

1.5

15.49

25.22

umol/l

10.44

248

1166

Systemic connective tissue disorders

161

646

2.51

25.96

1.7

1.5

20.49

25.54

umol/l

1.40

153

611

Asthma (only as main-diagnosis)

287

852

2.04

25.44

1.7

1.5

22.69

26.78

umol/l

1.41

275

808

Hypertensive diseases (excluding secondary)

260

716

2.12

25.22

1.5

18.79

29.14

umol/l

7.00

254

680

Pain (limb, back, neck, head abdominally)

297

733

2.04

24.99

1.6

22.81

26.01

umol/l

0.95

284

696

COPD differential diagnosis

335

866

1.94

24.82

1.5

24.31

26.50

umol/l

0.58

320

822

ILD differential diagnosis

335

866

1.94

24.81

1.5

24.31

26.50

umol/l

0.58

320

822

Sleep apnoea

352

1288

1.86

24.63

1.5

1.4

23.55

26.08

umol/l

0.79

331

1226

Pneumonias (Asthma/COPD co-morbidities)

416

1647

1.75

24.21

1.9

1.5

19.23

25.81

umol/l

5.39

398

1569

Neurological diseases, wide definition

166

322

2.60

24.08

1.8

1.5

21.69

28.50

umol/l

1.88

158

313

Recurring oral aphthae

5.68

24.04

1.6

1.5

18.08

20.40

umol/l

0.23

Visual disturbances and blindness

212

991

2.15

23.99

1.6

1.5

24.44

24.48

umol/l

0.01

200

946

Asthma-related infections

246

1198

2.03

23.82

1.8

1.5

19.87

24.58

umol/l

2.04

233

1145

Asthma, hospital admission 2, infections

246

1198

2.03

23.82

1.8

1.5

19.87

24.58

umol/l

2.04

233

1145

Sleep apnoea, including avohilmo

372

1338

1.81

23.68

1.5

1.4

24.11

26.17

umol/l

0.60

351

1272

All pneumoniae

417

1658

1.74

23.60

1.9

1.5

19.20

25.83

umol/l

5.49

399

1580

Visual disturbances

201

928

2.18

23.50

1.6

1.5

24.64

24.41

umol/l

0.03

189

888

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

401

1610

1.75

23.44

1.8

1.5

19.04

25.90

umol/l

5.66

384

1536

Cardiovascular diseases

323

923

1.91

23.42

1.7

22.91

26.30

umol/l

1.18

308

882

Dorsopathies

431

1258

1.75

23.38

1.6

1.5

24.14

26.00

umol/l

0.57

416

1199

Pneumonia, organism unspecified

365

1471

1.80

23.36

1.9

1.5

18.89

26.11

umol/l

5.63

349

1401

Personality disorders, excluding more controls

129

490

2.65

23.34

1.5

20.54

28.61

umol/l

2.48

122

469

Follow-up examination after treatment for conditions other than malignant neoplasms

166

447

2.44

23.07

1.4

1.3

21.97

29.55

umol/l

2.30

160

423

Hypokalaemia

160

4.04

23.02

3.4

1.3

17.60

23.81

umol/l

1.01

150

Symptoms and signs involving the nervous and musculoskeletal systems

234

1155

2.03

22.91

1.4

1.6

23.44

24.74

umol/l

0.28

227

1098

Dependence on enabling machines and devices, not elsewhere classified

10.97

22.76

2.5

2.4

15.80

18.45

umol/l

0.23

Other/unspecified dorsalgia

158

667

2.37

22.58

1.6

1.5

23.38

26.47

umol/l

0.61

152

633

Parasetamol

330

897

1.88

22.49

1.7

1.4

20.35

29.09

umol/l

5.84

312

860

203

950

2.13

22.45

1.9

1.6

19.23

24.82

umol/l

2.36

191

911

Renal tubulo-interstitial diseases

339

1439

1.81

22.45

1.8

1.4

16.74

26.31

umol/l

10.99

321

1372

KRA_PSY_EATING, excluding more controls

177

3.82

22.24

1.7

1.4

20.29

25.72

umol/l

0.78

172

Disorders of the thyroid gland

377

1399

1.77

22.23

1.4

1.5

25.92

24.64

umol/l

0.32

357

1335

Genitourinary diseases

259

636

2.05

22.21

1.8

1.6

19.51

26.96

umol/l

3.76

251

608

Finngen Rheumatological endpoints

407

1336

1.74

22.19

1.5

22.30

26.63

umol/l

2.01

389

1274

Ulcerative colitis, NAS

254

3.30

22.17

1.7

1.5

21.37

25.69

umol/l

0.69

240

Acute upper respiratory infections of multiple and unspecified sites

314

1282

1.84

21.81

1.7

1.5

22.01

24.56

umol/l

0.85

306

1224

Other specific joint derangements/joint disorders

318

1163

1.84

21.54

1.5

1.6

22.89

26.48

umol/l

1.31

301

1113

Behavioural syndromes associated with physiological disturbances and physical factors

168

748

2.26

21.51

1.6

21.76

24.68

umol/l

0.65

153

717

L04AA Selective immunosuppressants

120

460

2.63

21.40

2.0

1.5

16.01

24.88

umol/l

3.79

114

438

Gingivitis and periodontal diseases

339

959

1.83

21.27

1.5

20.09

28.00

umol/l

5.26

318

914

Symptoms and signs involving the skin and subcutaneous tissue

275

1465

1.87

21.27

1.5

23.69

25.25

umol/l

0.37

259

1394

COPD/asthma/ILD related infections

421

1237

1.71

20.86

1.6

1.4

24.38

26.71

umol/l

0.77

397

1175

COPD/asthma related infections

421

1237

1.71

20.86

1.6

1.4

24.38

26.71

umol/l

0.77

397

1175

Obesity related asthma

145

618

2.36

20.61

1.6

1.5

20.77

25.88

umol/l

1.33

136

591

Acute upper respiratory infections

408

1518

1.69

20.39

1.5

24.02

25.13

umol/l

0.31

389

1441

Cholelithiasis, broad definition with cholecystitis

321

1227

1.80

20.35

1.8

1.4

20.38

27.04

umol/l

3.94

309

1164

Other diseases of urinary system

410

1365

1.69

20.29

1.7

1.5

22.29

25.85

umol/l

1.61

393

1298

Other systemic involvement of connective tissue (FG)

115

441

2.60

20.19

1.6

1.4

21.31

27.56

umol/l

1.41

109

418

Other symptoms and signs involving the digestive system and abdomen

280

3.06

20.11

1.6

1.4

22.29

26.47

umol/l

0.59

270

Other diseases of upper respiratory tract

429

1337

1.68

20.10

1.6

1.5

25.29

24.09

umol/l

0.32

407

1273

Chronic sinusitis

177

828

2.15

20.07

2.1

1.4

23.89

25.73

umol/l

0.35

167

788

Acute renal failure

255

3.16

20.01

1.7

1.5

12.69

25.38

umol/l

6.02

243

Spondylopathies

278

898

1.88

19.95

1.6

1.4

21.96

27.27

umol/l

2.07

263

850

Exposure to unspecified factor

385

1780

1.68

19.83

1.7

1.5

20.24

25.28

umol/l

3.13

367

1696

Neoplasms

346

1050

1.77

19.77

1.6

26.94

22.60

umol/l

1.59

331

1004

Other symptoms and signs involving the nervous and musculoskeletal systems

179

849

2.12

19.63

1.3

1.6

26.49

24.93

umol/l

0.27

174

807

438

1402

1.65

19.55

1.6

1.4

23.79

25.55

umol/l

0.56

414

1332

Papulosquamous disorders

161

734

2.20

19.53

1.2

1.5

18.80

26.06

umol/l

2.97

154

698

Symptoms and signs involving cognition, perception, emotional state and behaviour

367

1514

1.70

19.43

1.6

1.5

23.33

25.41

umol/l

0.63

343

1445

Vasomotor and allergic rhinitis

178

834

2.11

19.36

1.5

1.6

24.50

23.87

umol/l

0.10

171

802

Bronchitis

412

1644

1.65

19.01

1.7

1.5

21.98

25.56

umol/l

1.69

395

1560

Hypoplasia of dental enamel, including avohilmo

7.64

19.00

2.9

2.4

15.28

14.00

umol/l

0.20

Migraine

223

976

1.95

19.00

1.7

1.5

23.52

26.29

umol/l

0.71

212

932

Soft tissue disorders

420

1317

1.66

18.98

1.5

1.6

24.09

24.81

umol/l

0.18

404

1259

Sciatica+with lumbago

192

896

2.04

18.97

1.5

1.4

19.95

27.10

umol/l

3.31

181

849

Osteopathies and chondropathies

210

1011

1.98

18.97

1.9

1.5

19.79

25.62

umol/l

2.35

199

957

Other intervertebral disc disorders

302

1030

1.80

18.81

1.5

1.4

19.79

27.16

umol/l

4.62

292

980

Other headache syndromes

178

857

2.09

18.79

1.6

1.4

22.03

26.91

umol/l

1.45

170

815

Other heart diseases

220

737

1.98

18.56

1.5

1.6

24.64

28.36

umol/l

0.92

209

702

Cholelithiasis

305

1212

1.77

18.49

1.7

1.4

19.95

27.00

umol/l

4.28

294

1150

Other diseases of the digestive system

110

435

2.54

18.44

2.3

1.4

16.41

23.73

umol/l

2.60

104

417

Other systemic involvement of connective tissue

122

510

2.41

18.18

1.8

1.4

20.58

25.62

umol/l

1.13

116

482

Hypertension

322

1042

1.75

18.08

1.5

18.95

27.72

umol/l

6.66

313

990

Pain in throat and chest

323

1136

1.74

18.06

1.4

1.6

26.24

24.56

umol/l

0.40

298

1090

Hypertensive diseases

322

1044

1.75

17.98

1.5

18.95

27.69

umol/l

6.62

313

992

Benign neoplasms

326

1062

1.74

17.89

1.6

24.33

22.61

umol/l

0.45

313

1014

Noninfectious colitis NAS

253

3.03

17.73

2.4

1.5

23.84

umol/l

0.00

240

Chronic rhinitis, nasopharyngitis and pharyngitis

134

593

2.27

17.53

1.5

30.51

25.14

umol/l

0.98

129

569

Cystitis

344

1246

1.69

17.37

1.7

1.4

23.19

25.90

umol/l

0.93

330

1183

Osteoporosis

342

2.66

17.36

2.5

1.4

17.29

26.46

umol/l

2.69

319

Other and unspecified effects of external causes

139

628

2.23

17.33

1.6

23.02

24.50

umol/l

0.24

130

599

Disorders of lacrimal system

168

818

2.06

17.27

1.7

1.4

21.41

26.10

umol/l

1.31

157

769

Selective serotonin reuptake inhibitors

371

1173

1.67

17.22

1.6

1.5

20.09

26.62

umol/l

4.35

352

1121

Dyspnoea

324

1470

1.69

17.12

1.5

22.92

25.62

umol/l

0.86

303

1400

Disorders of eyelid, lacrimal system and orbit

310

1427

1.71

17.03

1.5

22.15

25.93

umol/l

1.45

297

1354

Use of hypnotics and sedatives

396

1411

1.63

17.01

1.6

1.5

22.54

25.61

umol/l

1.20

374

1347

Heart failure, not strict

248

934

1.84

16.95

1.5

14.39

27.21

umol/l

14.76

234

887

Continuous positive airway pressure

243

2.89

16.88

1.7

17.62

29.91

umol/l

3.63

236

Abnormalities of heart beat

135

605

2.22

16.76

1.2

1.5

29.92

24.83

umol/l

0.92

124

579

Candidiasis

267

2.91

16.74

2.8

1.4

14.45

23.13

umol/l

3.43

255

Persons encountering health services in other circumstances

154

735

2.10

16.67

1.7

1.4

22.37

25.19

umol/l

0.57

143

701

Diseases of the musculoskeletal system and connective tissue

254

689

1.85

16.65

1.6

23.10

26.45

umol/l

0.94

245

659

GI-bleeding

106

433

2.46

16.64

2.3

1.4

15.96

24.09

umol/l

3.10

415

Viral infections characterized by skin and mucous membrane lesions

175

877

2.00

16.60

1.7

19.73

24.42

umol/l

1.62

169

839

Urticaria and erythema

172

858

2.01

16.57

1.8

1.6

20.28

26.21

umol/l

2.20

165

822

Diseases of salivary glands

307

2.75

16.55

1.6

27.23

29.84

umol/l

0.30

299

Acute sinusitis

216

1083

1.87

16.44

1.8

1.5

23.32

25.19

umol/l

0.41

205

1033

Exclusions for E4_PCOS_CONSORTIUM

330

1235

1.68

16.33

1.7

1.5

24.18

25.49

umol/l

0.33

316

1181

Asthma, unspecified (mode), excluding more controls

184

731

1.98

16.27

1.8

1.5

22.11

27.50

umol/l

1.64

175

696

Myalgia

106

438

2.43

16.27

1.5

22.52

26.17

umol/l

0.63

418

Hypothyroidism, strict autoimmune, 3 medication purchases required

326

1332

1.67

16.20

1.4

1.5

24.41

25.44

umol/l

0.24

309

1269

All influenza

105

433

2.44

16.17

2.1

1.5

17.14

25.62

umol/l

3.00

413

Nerve, nerve root and plexus disorders

379

1477

1.62

16.17

1.4

1.5

20.37

26.58

umol/l

4.11

359

1404

Nonorganic sleeping disorders, excluding more controls

324

2.67

15.99

1.5

1.4

24.91

28.18

umol/l

0.41

309

Other disorders of lacrimal gland

140

659

2.13

15.79

1.7

1.5

20.06

26.48

umol/l

1.95

130

623

Fissure and fistula of anal and rectal regions

397

2.48

15.71

1.9

1.3

17.36

25.78

umol/l

2.62

379

Hypertension, essential

296

984

1.72

15.70

1.5

21.03

28.13

umol/l

3.80

285

934

Irregular menses

230

1032

1.82

15.68

1.6

1.4

22.60

26.57

umol/l

1.27

215

986

Antihypertensive medication - note that there are other indications

301

962

1.72

15.68

1.6

23.82

25.75

umol/l

0.50

285

917

Substance abuse, excluding more controls

183

828

1.94

15.55

1.8

1.4

13.37

27.66

umol/l

19.82

176

790

Cholecystectomy

253

1281

1.75

15.54

1.8

1.4

20.86

26.27

umol/l

2.40

248

1208

Diseases of the respiratory system

255

708

1.81

15.51

1.6

1.5

23.26

27.03

umol/l

1.09

243

670

Asthma, unspecified (mode)

186

763

1.94

15.48

1.8

1.5

21.98

27.09

umol/l

1.55

177

724

Benign neoplasms

379

1320

1.61

15.44

1.6

1.5

23.58

24.56

umol/l

0.25

366

1260

Other gastritis (incl. Duodenitis)

331

2.61

15.34

2.0

1.4

15.06

25.06

umol/l

4.05

316

Other acute lower respiratory infections

202

1041

1.86

15.28

2.0

1.6

21.34

24.16

umol/l

0.73

193

994

Diseases of the eye and adnexa

345

1049

1.65

15.27

1.6

25.28

24.44

umol/l

0.18

327

1004

Epilepsy

126

575

2.19

15.26

2.2

1.7

18.03

24.14

umol/l

2.12

121

549

Eating disorder

228

2.97

15.09

1.7

1.6

20.29

23.09

umol/l

0.35

219

Asthma (diagnoses ohter than nonallergic)

331

1753

1.62

15.08

1.7

1.5

22.54

24.89

umol/l

0.78

316

1671

Bleeding

275

1172

1.71

15.07

1.9

1.4

19.31

25.43

umol/l

3.31

264

1107

Polycystic ovarian syndrome, consortium definition

318

1159

1.66

14.99

1.5

1.4

22.34

26.58

umol/l

1.75

296

1103

Asthma-related pneumonia

133

628

2.12

14.85

2.0

1.5

20.14

24.69

umol/l

1.18

127

601

Other disorders of urethra and urinary system

264

1154

1.72

14.79

1.7

1.4

21.78

26.02

umol/l

1.56

250

1095

Asthma-related pneumonia or sepsis

133

630

2.12

14.73

2.0

1.5

20.14

24.66

umol/l

1.17

127

603

Asthma, hospital admissions 3, pneumonia

133

630

2.12

14.73

2.0

1.5

20.14

24.66

umol/l

1.17

127

603

Eating disorders

260

2.79

14.57

1.7

1.6

19.64

23.79

umol/l

0.64

250

Asthma/COPD (KELA code 203)

367

1645

1.58

14.50

1.7

1.5

22.98

25.32

umol/l

0.81

350

1564

Cough

157

762

1.98

14.50

1.5

1.6

24.77

23.77

umol/l

0.15

148

730

Covid-19 confirmed case

120

551

2.19

14.46

1.9

1.6

19.36

23.51

umol/l

0.91

108

525

Personality disorders

129

613

2.12

14.26

1.5

20.54

26.17

umol/l

1.51

122

585

Psoriasis

119

548

2.18

14.25

1.3

1.5

18.23

24.99

umol/l

2.23

113

523

Molar incisor enamel hypoplasia, with caries

7.15

14.18

2.1

2.9

15.90

15.19

umol/l

0.08

Chronic diseases of tonsils and adenoids

313

1213

1.64

14.18

1.4

1.6

26.58

24.32

umol/l

0.59

296

1155

Dental operations

225

636

1.82

14.10

1.5

20.18

28.95

umol/l

4.12

212

606

Disorders of adult personality and behaviour

135

656

2.07

14.07

1.5

20.14

25.73

umol/l

1.60

128

627

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

180

947

1.87

13.94

1.5

23.88

24.87

umol/l

0.16

169

904

Provisional assignment of new diseases of uncertain etiology

181

977

1.86

13.88

1.8

1.5

21.87

24.88

umol/l

0.72

167

938

Deforming dorsopathies

112

509

2.21

13.86

1.2

1.5

24.67

26.25

umol/l

0.21

106

485

Codes for special purposes

181

980

1.85

13.75

1.8

1.5

21.87

24.93

umol/l

0.74

167

940

Intracranial trauma

212

887

1.79

13.72

1.8

1.5

20.88

27.39

umol/l

2.75

200

852

Concussion

181

843

1.86

13.68

2.0

1.5

21.96

27.10

umol/l

1.61

170

808

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

129

477

2.12

13.67

1.8

1.4

30.46

21.73

umol/l

1.92

122

446

Asthma, including avohilmo

440

1704

1.50

13.60

1.6

1.5

23.05

24.78

umol/l

0.59

417

1625

Chronic lower respiratory diseases

457

1657

1.49

13.54

1.7

1.5

21.81

25.26

umol/l

1.73

437

1576

Benign neoplasm: Colon

152

590

1.98

13.45

1.6

1.4

22.34

23.14

umol/l

0.12

147

551

Diseases of the ear and mastoid process

447

1507

1.50

13.44

1.5

23.84

25.18

umol/l

0.40

436

1431

Allergic rhinitis

152

778

1.94

13.33

1.5

1.7

25.63

23.84

umol/l

0.30

146

746

Conjunctivitis

302

1655

1.59

13.05

1.4

1.6

26.36

24.53

umol/l

0.47

288

1576

Falls/tendency to fall

435

1452

1.50

13.04

1.6

1.5

20.49

26.56

umol/l

4.37

414

1390

Other viral diseases

139

702

1.98

12.96

2.0

1.7

24.60

23.48

umol/l

0.17

133

672

Diseases of liver

126

616

2.05

12.96

1.8

1.5

17.41

25.61

umol/l

3.15

121

587

Other joint disorders

352

1198

1.57

12.95

1.5

1.6

23.76

26.11

umol/l

0.71

333

1146

Disorders of conjunctiva

321

1717

1.57

12.89

1.4

1.6

25.89

24.17

umol/l

0.46

307

1636

Polyarthropathies

244

960

1.70

12.88

1.4

1.5

20.99

27.39

umol/l

2.71

228

918

Syncope and collapse

129

562

2.04

12.77

1.7

1.4

21.16

26.63

umol/l

1.33

122

529

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

376

2.35

12.66

1.6

1.5

25.75

24.79

umol/l

0.10

359

Arthropathies

368

1213

1.55

12.65

1.6

23.32

25.99

umol/l

0.89

352

1161

Other heart diseases, wide

356

1436

1.54

12.55

1.5

1.6

24.26

25.77

umol/l

0.40

338

1376

Adverse effects, not elsewhere classified

100

453

2.22

12.55

1.7

1.6

19.06

23.59

umol/l

1.05

433

Ulcerative colitis (strict definition, require KELA)

347

2.41

12.54

1.5

26.62

25.09

umol/l

0.16

332

Non-selective monoamine reuptake inhibitors

130

630

2.01

12.54

1.5

1.4

18.78

27.82

umol/l

3.53

124

599

Acute tubulo-interstitial nephritis

216

1120

1.71

12.46

1.7

1.4

17.50

26.37

umol/l

6.43

204

1065

Benign neoplasm: Colon

152

787

1.90

12.45

1.6

1.4

22.34

25.67

umol/l

0.70

147

740

Coagulation defects, purpura and other haemorrhagic conditions

379

2.34

12.44

2.0

1.5

14.22

24.24

umol/l

4.86

362

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

185

645

1.82

12.36

1.7

1.5

20.86

29.98

umol/l

3.92

179

613

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

338

2.41

12.30

1.6

1.5

26.23

25.15

umol/l

0.11

324

Type 2 diabetes

343

1317

1.55

12.30

1.4

1.5

20.01

27.20

umol/l

4.75

321

1259

Cardiac arrhythmias

240

945

1.68

12.27

1.5

26.34

28.09

umol/l

0.34

229

909

Dizziness and giddiness

249

1230

1.65

12.19

1.5

1.4

27.20

25.76

umol/l

0.27

231

1172

Lichen ruber planus, wide definition including periferal and oral lichen planus

364

2.35

12.18

1.3

1.4

23.43

25.36

umol/l

0.23

345

Shoulder lesions

251

925

1.66

12.15

1.3

1.5

24.05

26.22

umol/l

0.51

236

879

Fibromyalgia

175

3.00

12.05

1.6

1.4

23.39

26.12

umol/l

0.24

165

Acute bronchitis

149

776

1.89

12.03

2.0

1.5

19.31

24.23

umol/l

1.50

144

743

Menorrhagia

156

448

1.93

12.02

1.4

1.5

24.72

26.81

umol/l

0.34

144

425

Symptoms and signs involving the urinary system

246

1157

1.65

11.96

1.7

1.5

19.57

25.81

umol/l

3.04

233

1097

Lumbar disc prolapse

209

970

1.72

11.91

1.6

1.4

20.78

27.60

umol/l

2.99

203

923

Fall on same level

435

1662

1.46

11.83

1.6

1.5

20.87

25.72

umol/l

3.04

411

1587

Dental caries 2

307

1556

1.55

11.76

1.6

1.5

25.51

24.68

umol/l

0.18

298

1477

Other symptoms and signs involving cognitive functions and awareness

132

636

1.95

11.73

1.6

1.5

17.83

24.81

umol/l

2.59

124

605

Allergic conjunctivitis

233

1399

1.64

11.68

1.4

1.5

27.03

25.20

umol/l

0.39

221

1331

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

224

1330

1.66

11.67

1.4

1.5

27.60

25.11

umol/l

0.56

213

1263

Excessive, frequent and irregular menstruation

174

528

1.84

11.60

1.5

1.4

21.14

26.53

umol/l

1.66

162

502

Diabetes, varying definitions

372

1487

1.50

11.46

1.6

1.5

20.54

26.36

umol/l

3.55

350

1424

Diabetes mellitus

374

1497

1.49

11.38

1.6

1.5

20.50

26.29

umol/l

3.54

351

1435

Asthma, hospital admissions , main diagnosis only

305

1781

1.54

11.36

1.6

1.5

22.35

24.80

umol/l

0.80

292

1697

Benign neoplasm of colon, rectum, anus and anal canal

167

658

1.82

11.36

1.6

1.4

22.22

23.33

umol/l

0.19

162

617

Benign neoplasm of colon, rectum, anus and anal canal

175

899

1.76

11.19

1.6

1.4

22.55

25.34

umol/l

0.61

170

842

Inflammatory diseases of female pelvic organs

257

1212

1.60

11.17

1.5

1.4

21.02

26.77

umol/l

2.70

245

1147

Spinal stenosis

139

574

1.90

11.11

1.3

18.02

27.74

umol/l

3.98

133

540

Dental caries 2 and operation codes

300

1552

1.54

11.07

1.6

1.5

25.93

24.75

umol/l

0.26

291

1473

Other immunodeficiencies

7.54

11.06

2.4

1.5

27.64

16.06

umol/l

0.64

Specific personality disorders

108

531

2.04

11.03

1.5

1.6

20.40

26.07

umol/l

1.38

102

508

Haemorrhage from respiratory passages

102

453

2.10

11.02

1.9

1.5

23.53

24.91

umol/l

0.17

438

Sleep disorders

460

2.12

10.91

1.5

1.6

25.42

25.24

umol/l

0.02

441

Type 2 diabetes, wide definition

244

985

1.62

10.77

1.5

1.4

16.07

27.20

umol/l

10.30

226

936

Urticaria

132

702

1.89

10.75

1.7

1.5

19.43

25.32

umol/l

1.93

126

673

Accidents

325

1065

1.53

10.74

1.7

1.5

23.44

27.17

umol/l

1.31

309

1018

Other neurological diseases

219

1074

1.64

10.68

1.6

1.5

21.34

25.33

umol/l

1.23

209

1017

Other external causes of accidental injury

324

1065

1.53

10.57

1.7

1.5

23.57

27.17

umol/l

1.23

308

1018

Colonic or urogenital fistula

104

513

2.04

10.55

1.8

1.5

16.96

25.76

umol/l

3.22

490

Benign neoplasm of other and ill-defined parts of digestive system

247

2.52

10.46

1.6

1.3

18.44

20.29

umol/l

0.22

233

Type 2 diabetes, definitions combined

313

1231

1.52

10.41

1.5

1.4

19.20

27.52

umol/l

5.97

295

1174

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

314

1354

1.51

10.38

1.6

1.4

21.64

26.44

umol/l

2.17

305

1275

Ovarian cyst

157

500

1.82

10.33

1.5

1.4

23.29

26.33

umol/l

0.60

151

474

Spondylosis

153

737

1.78

10.20

1.4

23.30

27.57

umol/l

0.97

143

701

Disorders of sclera, cornea, iris and ciliary body

185

1106

1.68

10.13

1.6

1.5

21.71

25.73

umol/l

1.13

173

1054

Exposure to other specified factors

261

1589

1.54

10.06

1.5

21.70

24.73

umol/l

0.98

250

1512

Rheumatism, unspecified

246

2.49

10.05

1.6

1.5

20.56

26.75

umol/l

0.92

231

Hernia

315

1429

1.50

10.04

1.8

1.4

21.22

26.06

umol/l

2.24

303

1350

Type 2 diabetes, strict (exclude DM1)

312

1243

1.50

9.82

1.5

18.95

27.45

umol/l

6.31

294

1185

Sequelae with surgical and medical care as external cause

329

2.26

9.81

2.4

1.4

18.51

24.29

umol/l

1.04

314

Disturbances of skin sensation

110

570

1.94

9.74

1.7

1.5

28.74

25.04

umol/l

0.52

102

544

Lichen planus, including avohilmo

306

2.30

9.67

1.3

1.4

20.26

26.73

umol/l

1.13

288

External causes of morbidity and mortality

261

837

1.57

9.57

1.7

1.5

23.00

27.59

umol/l

1.56

249

798

Sequelae of external causes of morbidity and mortality

438

2.06

9.52

2.3

1.4

18.26

24.54

umol/l

1.41

418

Diverticular disease of intestine

191

764

1.66

9.51

1.4

1.3

22.33

26.42

umol/l

1.11

184

724

Deviated nasal septum

103

526

1.96

9.50

1.4

1.5

25.18

23.73

umol/l

0.18

505

Insomnia

341

2.21

9.45

1.5

27.36

24.45

umol/l

0.31

328

Nonorganic sleeping disorders

414

2.09

9.38

1.5

1.6

24.91

24.12

umol/l

0.08

395

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

310

1234

1.49

9.35

1.6

1.5

33.71

22.81

umol/l

5.74

298

1173

Abnormal findings on examination of blood, without diagnosis

135

706

1.79

9.34

1.8

1.5

19.89

23.79

umol/l

1.00

130

677

Glomerular diseases

311

2.26

9.32

1.6

12.09

23.66

umol/l

6.03

296

Unspecified fall

166

979

1.69

9.32

1.7

1.6

16.82

24.59

umol/l

4.43

159

935

Other local infections of skin and subcutaneous tissue

174

2.72

9.23

2.6

1.5

14.37

26.12

umol/l

3.02

164

Type 2 diabetes, definitions combined, including avohilmo

312

1249

1.48

9.23

1.5

19.50

27.37

umol/l

5.37

296

1191

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

309

1233

1.48

9.22

1.6

1.5

33.81

22.82

umol/l

5.80

297

1172

Reimbursement for rheumatic diseases

198

1233

1.61

9.19

1.4

1.5

19.77

26.03

umol/l

2.54

188

1170

Malignant neoplasm, wide definition for exclusion

309

1234

1.48

9.19

1.6

1.5

33.81

22.81

umol/l

5.82

297

1173

Other arthrosis

162

678

1.71

9.14

1.3

1.5

19.15

28.87

umol/l

4.38

153

653

Substance abuse

183

1073

1.63

9.06

1.8

1.5

13.37

26.14

umol/l

19.05

176

1023

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

129

722

1.79

9.01

1.6

1.5

29.05

25.18

umol/l

0.65

124

690

All influenza (not pneumonia)

261

2.35

8.88

2.0

1.5

19.07

24.46

umol/l

0.84

249

Rotator cuff syndrome

180

816

1.64

8.75

1.3

1.4

20.68

26.53

umol/l

2.09

169

777

Other congenital malformations of the digestive system

118

3.07

8.74

4.0

2.1

23.44

20.52

umol/l

0.23

113

Injuries to the knee and lower leg

413

1701

1.39

8.72

1.6

1.5

22.86

25.06

umol/l

0.79

392

1619

Temporomandibular joint disorders, including avohilmo

170

1035

1.65

8.72

1.3

1.5

26.71

25.36

umol/l

0.22

160

993

Tonsillectomy and adenotomy

249

1142

1.52

8.68

1.6

1.7

23.69

24.53

umol/l

0.17

237

1094

Disorders of ocular muscles, binocular movement, accommodation and refraction

181

1114

1.62

8.63

1.9

1.6

22.09

24.96

umol/l

0.70

174

1070

Migraine with aura

517

1.92

8.62

1.5

20.48

27.26

umol/l

1.63

491

Functional dyspepsia

506

1.92

8.49

1.4

23.94

26.23

umol/l

0.31

482

Other and unspecified local infections of skin and subcutaneous tissue

165

2.69

8.47

2.7

1.5

14.54

26.53

umol/l

2.85

155

Injuries to the abdomen, lower back, lumbar spine and pelvis

127

717

1.76

8.43

1.7

1.5

17.79

24.67

umol/l

2.53

121

683

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

183

1063

1.60

8.31

1.5

23.16

24.93

umol/l

0.34

172

1007

Insulin medication

181

965

1.61

8.30

1.7

1.6

18.43

25.61

umol/l

3.16

167

922

Injury, poisoning and certain other consequences of external causes

219

699

1.57

8.29

1.7

1.5

22.51

26.93

umol/l

1.35

210

670

Excessive attrition of teeth

144

448

1.75

8.28

1.3

1.6

20.55

24.65

umol/l

0.94

137

429

Intracranial injury

185

1126

1.59

8.28

2.0

1.6

19.36

24.70

umol/l

2.22

174

1079

Amenorrhoea

162

2.68

8.22

2.1

1.6

16.57

24.38

umol/l

1.30

155

Mental and behavioural disorders due to psychoactive substance use

185

1101

1.59

8.21

1.8

1.5

13.98

26.12

umol/l

14.84

178

1050

Gonarthrosis

200

722

1.59

8.20

1.3

1.5

21.16

28.24

umol/l

2.67

192

692

Insulin, combination of fast acting with intermediate-acting or long-acting

181

1047

1.60

8.18

1.7

1.6

18.43

24.59

umol/l

2.51

167

1002

Chronic periodontitis, complicated

140

2.81

8.16

1.4

1.3

19.39

25.82

umol/l

0.73

133

Xerosis cutis

6.64

8.10

1.7

1.3

18.24

19.04

umol/l

0.03

Noninflammatory disorders of female genital tract

176

539

1.65

8.02

1.6

1.4

23.24

26.39

umol/l

0.70

169

513

Convalescence

3.36

7.94

1.4

1.3

14.65

28.88

umol/l

2.47

Triptan medication for migraine, min. 3 purchases

227

1186

1.51

7.93

1.6

1.5

25.94

26.06

umol/l

0.02

220

1128

Dental caries 1 and operation codes

283

991

1.47

7.84

1.5

19.70

27.55

umol/l

4.86

270

941

Benign neoplasm of other and ill-defined parts of digestive system

283

2.20

7.81

1.6

1.3

18.44

24.68

umol/l

1.03

269

Other cataract

125

555

1.75

7.76

1.4

19.76

25.91

umol/l

1.57

117

523

Impingement syndrome of shoulder

404

1.99

7.73

1.4

1.5

24.89

27.47

umol/l

0.31

385

Parodontitis or operation codes

276

1404

1.45

7.72

1.4

1.5

19.36

26.70

umol/l

4.53

257

1334

Endometriosis of pelvic peritoneum

319

2.11

7.72

1.4

28.20

27.98

umol/l

0.02

304

Other diseases of blood and blood-forming organs, wide

405

1.98

7.68

1.7

1.5

20.85

24.54

umol/l

0.58

385

Parodontitis and operation codes

260

1384

1.46

7.68

1.3

1.5

19.93

26.44

umol/l

3.40

241

1315

Dental operations, only avohilmo

224

751

1.53

7.61

1.5

1.6

19.33

28.03

umol/l

4.53

212

716

Diabetes medication

350

1530

1.39

7.57

1.5

20.26

26.33

umol/l

3.71

327

1463

Cervicocranial syndrome

181

2.50

7.56

1.6

1.3

26.52

24.13

umol/l

0.16

170

Triptan medication for migraine, single purchase ok

292

1383

1.43

7.54

1.5

27.92

25.15

umol/l

0.75

281

1310

Migraine, single triptan purchase ok & required. ICD-code if available is included

292

1383

1.43

7.54

1.5

27.92

25.15

umol/l

0.75

281

1310

Chronic periodontitis, including avohilmo

273

1402

1.44

7.47

1.4

1.5

19.44

26.67

umol/l

4.35

254

1332

Parodontitis

274

1404

1.44

7.43

1.4

1.5

19.41

26.70

umol/l

4.43

255

1334

Haemorrhoids and perianal venous thrombosis

396

1.97

7.42

1.3

26.71

25.96

umol/l

0.07

373

Atrial fibrillation and flutter with reimbursement

233

2.07

7.42

1.4

23.29

31.55

umol/l

1.23

215

Heart failure and bmi 25plus

290

1.98

7.40

1.4

13.53

21.34

umol/l

2.59

277

Other arrhythmias

205

1033

1.52

7.36

1.4

1.5

23.79

26.90

umol/l

0.76

195

986

Insulin, intermediate and long-acting

158

970

1.60

7.34

1.6

1.5

19.31

24.54

umol/l

1.60

145

930

Dental caries 2, only avohilmo

283

1569

1.42

7.32

1.5

26.49

24.58

umol/l

0.45

274

1490

Other diseases of pleura

115

585

1.75

7.31

1.4

1.5

21.98

23.12

umol/l

0.16

108

557

Diseases of inner ear

157

963

1.60

7.27

1.4

24.70

25.54

umol/l

0.12

146

916

Other shoulder lesions

168

2.52

7.16

1.5

1.4

26.18

24.46

umol/l

0.12

158

Other and unspecified rosacea

139

2.68

7.15

1.4

1.5

18.79

27.25

umol/l

1.17

131

Other inflammatory liver diseases

106

2.95

7.12

1.9

1.3

15.16

26.42

umol/l

1.90

Dental caries, including avohilmo

253

885

1.46

6.99

1.5

20.30

28.15

umol/l

4.15

241

843

Dental caries 1

253

885

1.46

6.98

1.5

20.30

28.15

umol/l

4.15

241

843

Endometriosis

134

475

1.68

6.95

1.4

28.30

26.82

umol/l

0.19

122

450

Other (not insulin) diabetes medications

298

1278

1.41

6.91

1.4

19.70

27.52

umol/l

5.04

277

1216

Presence of other functional implants

144

627

1.63

6.86

1.5

1.3

23.22

25.08

umol/l

0.29

128

594

Fall on same level involving ice and snow

178

1166

1.53

6.84

1.6

1.5

20.55

25.86

umol/l

1.86

168

1107

Injuries to the hip and thigh

132

736

1.64

6.81

1.9

1.5

14.26

24.87

umol/l

7.98

124

699

Dental pulpitis 2

230

796

1.48

6.78

1.5

21.27

28.40

umol/l

3.07

219

759

Other disorders of ear

287

1361

1.41

6.77

1.5

22.57

25.02

umol/l

0.72

271

1292

Heart failure,strict

123

526

1.69

6.76

1.4

1.5

15.44

26.98

umol/l

5.55

117

498

Lichen planus

204

2.32

6.73

1.1

1.4

19.04

24.19

umol/l

0.64

192

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

108

550

1.73

6.67

1.3

1.4

42.69

22.17

umol/l

5.63

103

516

Postviral fatigue syndrome

12.63

6.63

1.2

1.0

20.75

20.74

umol/l

—

Diseases of middle ear and mastoid

209

1161

1.48

6.62

1.7

1.5

22.36

24.50

umol/l

0.50

198

1112

Phlebitis and thrombophlebitis (not including DVT)

400

1.91

6.58

1.8

1.4

17.83

25.64

umol/l

1.95

382

Dental pulpitis 2, only avohilmo

234

818

1.47

6.56

1.6

1.5

21.39

28.24

umol/l

2.90

223

780

Subjective visual disturbances

480

1.82

6.51

1.5

27.09

25.80

umol/l

0.13

463

Congenital malformations, deformations and chromosomal abnormalities

214

1408

1.46

6.51

1.8

1.5

22.61

24.80

umol/l

0.53

207

1341

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

304

1341

1.39

6.50

1.6

1.5

18.95

26.85

umol/l

5.54

279

1284

Gonarthrosis [arthrosis of knee](FG)

216

862

1.48

6.48

1.3

1.5

20.74

27.84

umol/l

3.03

208

822

Dental pulpitis 4

371

1431

1.35

6.47

1.7

1.5

22.52

26.43

umol/l

1.70

347

1370

Internal derangement of knee

117

704

1.66

6.39

1.4

1.5

25.53

27.84

umol/l

0.32

104

673

Diseases of pulp and periapical tissues, including avohilmo

370

1430

1.35

6.38

1.7

1.5

22.54

26.45

umol/l

1.69

346

1369

Pyoderma gangrenosum

6.90

6.36

1.5

1.2

29.60

17.46

umol/l

—

Heart failure, strict

131

579

1.63

6.33

1.4

1.5

15.97

25.28

umol/l

3.95

124

551

STROKE

169

764

1.54

6.32

1.3

1.5

21.96

28.28

umol/l

1.89

160

728

Symptoms and signs involving speech and voice

106

625

1.70

6.32

1.3

1.5

26.86

25.06

umol/l

0.23

100

596

All-cause Heart Failure

129

570

1.63

6.27

1.4

1.5

15.95

25.32

umol/l

3.90

122

542

Other medical care

108

626

1.69

6.26

1.6

1.5

38.24

24.36

umol/l

3.25

102

591

Dental pulpitis 1

369

1433

1.34

6.19

1.7

1.5

22.59

26.41

umol/l

1.63

345

1372

In situ neoplasms

103

577

1.71

6.19

1.3

1.4

24.83

23.94

umol/l

0.10

538

Other sleep disorders

168

2.39

6.19

1.5

1.4

23.36

26.45

umol/l

0.24

159

Abnormal findings on diagnostic imaging of lung

117

693

1.65

6.18

1.3

1.5

24.20

24.59

umol/l

0.05

108

658

Other abnormal uterine and vaginal bleeding

307

1.86

6.13

1.3

1.4

16.86

25.99

umol/l

2.48

288

Disorders of synovium and tendon

165

981

1.52

6.08

1.4

1.5

23.61

26.09

umol/l

0.47

154

933

Non-allergic asthma (mode), excluding more controls

305

1.99

5.99

1.8

1.6

23.22

24.87

umol/l

0.16

292

Dermatitis due to substances taken internally

3.00

5.96

1.7

1.5

14.03

23.02

umol/l

1.43

Disorders of vestibular function (Vertigo)

134

846

1.58

5.95

1.4

1.5

25.98

25.53

umol/l

0.05

124

803

Disorders of refraction and accommodation

108

650

1.66

5.91

2.0

1.6

20.75

23.83

umol/l

0.57

102

622

Dental caries 3

273

1002

1.39

5.89

1.5

1.6

19.79

28.23

umol/l

5.30

261

956

Birth asphyxia

5.76

5.87

3.6

2.0

13.95

12.05

umol/l

0.64

Other congenital malformations of intestine

5.66

5.85

8.3

1.4

26.20

19.40

umol/l

0.29

Insulin, fast-acting

115

708

1.63

5.83

1.7

1.6

16.44

23.68

umol/l

2.80

107

679

Exfoliative dermatitis

11.37

5.82

1.2

1.6

11.35

20.01

umol/l

—

Dental caries 3 and operation codes

292

1094

1.37

5.72

1.5

1.6

18.49

27.82

umol/l

7.38

278

1041

Unspecified mental disorder

137

887

1.55

5.64

1.5

22.96

26.13

umol/l

0.64

129

850

Diseases of arteries, arterioles and capillaries

163

811

1.50

5.60

1.6

1.4

18.48

25.38

umol/l

2.69

158

768

Non-allergic asthma (mode)

314

1.93

5.54

1.8

1.6

23.22

24.64

umol/l

0.13

299

Diabetes, insulin treatment (Kela reimbursement)

315

1439

1.34

5.54

1.6

1.5

18.67

26.71

umol/l

6.10

290

1377

Telogen effluvium

12.74

5.47

1.1

1.0

18.42

21.86

umol/l

—

Rosacea

211

2.14

5.43

1.4

1.5

22.49

26.21

umol/l

0.38

200

Malignant neoplasm

286

1252

1.36

5.42

1.6

1.5

34.75

22.89

umol/l

6.02

273

1187

TMD related operations

377

1.84

5.41

1.6

1.5

25.45

24.57

umol/l

0.08

357

In situ neoplasms

103

630

1.64

5.41

1.3

1.4

24.83

25.74

umol/l

0.11

597

Any event in cancer register

304

1344

1.34

5.40

1.5

32.45

23.17

umol/l

4.39

289

1281

Conductive and sensorineural hearing loss

220

1082

1.41

5.40

1.5

24.64

25.56

umol/l

0.16

208

1025

Insulin, fast-acting or short human

115

723

1.59

5.39

1.7

1.6

16.44

23.80

umol/l

2.89

107

693

Agranulocytosis

199

2.17

5.36

1.7

1.4

22.46

23.60

umol/l

0.09

187

Suppurative and unspecified otitis media

138

805

1.52

5.23

1.8

1.6

19.98

23.86

umol/l

0.98

130

772

Postmenopausal atrophic vaginitis

284

1.76

5.21

1.2

1.3

33.38

26.94

umol/l

0.83

267

6-mercaptopurine

3.37

5.17

1.5

1.8

28.45

27.19

umol/l

0.05

Bipolar affective disorders

383

1.81

5.16

1.3

1.5

18.08

28.08

umol/l

2.80

368

Keratitis

110

694

1.59

5.12

1.7

1.5

20.28

25.53

umol/l

1.20

104

664

Transport accidents

142

839

1.50

5.08

1.6

1.4

18.12

27.03

umol/l

4.31

137

802

Carpal tunnel syndrome

179

1128

1.43

5.07

1.4

19.15

27.05

umol/l

3.90

173

1071

Oral lichen ruber planus, including avohilmo

104

2.62

5.06

1.3

1.5

26.63

24.74

umol/l

0.11

Primary biliary cholangitis (PBC)

4.84

5.02

1.2

1.3

16.12

29.17

umol/l

0.71

Coxibs

285

1.70

4.95

1.6

19.51

24.17

umol/l

0.85

270

Other and unspecified mental retardation

3.28

4.92

2.9

2.5

12.39

17.52

umol/l

1.20

Impetigo

2.68

4.92

1.5

1.7

16.59

24.87

umol/l

1.01

Problems related to lifestyle

168

2.21

4.86

1.4

1.3

11.75

25.43

umol/l

7.28

160

Disorders of phosphorus metabolism and phosphatases

9.43

4.85

4.8

1.7

18.61

27.47

umol/l

—

Sensorineural hearing loss

199

994

1.40

4.82

1.5

25.10

25.23

umol/l

0.02

187

938

Digestive system disorders of fetus and newborn

16.43

4.76

7.1

1.6

11.27

11.12

umol/l

—

Non-rheumatic valve diseases

116

545

1.56

4.74

1.3

1.6

20.04

26.76

umol/l

1.72

108

520

Redundant prepuce, phimosis and paraphimosis

284

1.90

4.73

2.0

1.7

10.98

25.69

umol/l

11.79

270

Arthrosis

211

833

1.39

4.73

1.4

1.5

20.12

28.13

umol/l

3.71

201

794

Other and unspecified tonsillitis

120

665

1.53

4.72

2.0

1.6

22.01

24.52

umol/l

0.43

113

638

Certain conditions originating in the perinatal period

215

1.99

4.71

3.0

1.9

19.25

21.08

umol/l

0.19

207

Biguanides

275

1276

1.33

4.67

1.5

18.08

27.12

umol/l

7.09

257

1210

Rheumatoid arthritis

523

1.62

4.66

1.3

1.4

22.75

29.45

umol/l

1.29

501

Retention of urine

376

1.71

4.65

1.8

1.5

15.68

25.24

umol/l

3.22

358

Dislocation, sprain and strain of joints and ligaments of knee

192

1284

1.39

4.63

1.6

1.5

21.87

25.76

umol/l

1.15

183

1224

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

139

606

1.49

4.61

1.4

1.5

24.69

25.00

umol/l

0.04

133

578

Degeneration of macula and posterior pole

494

1.60

4.58

1.3

25.79

25.51

umol/l

0.03

469

Other arthritis (FG)

573

1.61

4.57

1.3

1.6

23.15

26.52

umol/l

0.52

550

Varicose veins

171

911

1.42

4.52

1.5

1.3

21.27

26.40

umol/l

1.54

164

854

Unspecified haematuria

536

1.58

4.52

2.1

1.5

16.88

25.36

umol/l

2.79

512

Disorders of breast

172

1132

1.41

4.51

1.3

1.4

26.02

26.57

umol/l

0.08

165

1067

Obsessive-compulsive disorder

129

2.34

4.50

2.0

1.5

32.70

26.21

umol/l

0.46

122

Valvular heart disease excluding rheumatic fever

117

559

1.53

4.49

1.3

1.6

19.99

26.40

umol/l

1.63

109

533

Other postsurgical states

2.54

4.46

2.4

1.8

10.42

21.25

umol/l

3.91

Iridocyclitis

432

1.69

4.43

1.5

1.6

22.35

24.71

umol/l

0.27

412

Explicit bacterial Sepsis

149

2.22

4.42

2.2

1.4

17.86

25.34

umol/l

0.88

142

Mouth breathing

123

825

1.49

4.39

1.6

26.95

23.86

umol/l

0.48

117

790

Sulfasalazine

502

1.64

4.38

1.5

1.4

16.59

25.91

umol/l

3.06

484

Acute suppurative otitis media

104

628

1.55

4.38

2.0

1.7

19.59

23.59

umol/l

0.87

600

Injuries to the elbow and forearm

218

1463

1.35

4.35

1.6

1.5

23.26

25.24

umol/l

0.45

206

1394

Behçet disease

12.34

4.34

1.6

1.0

11.29

13.52

umol/l

—

Hypoplasia of dental enamel, prenatal

7.83

4.32

2.3

2.8

13.54

11.43

umol/l

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

302

1.83

4.32

1.5

1.3

14.15

25.60

umol/l

3.49

287

Acute and subacute iridocyclitis

369

1.74

4.28

1.5

22.29

24.70

umol/l

0.26

351

Unspecified urinary incontinence

152

2.18

4.24

1.2

1.4

19.48

20.87

umol/l

0.10

142

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

446

1.66

4.22

1.3

1.5

24.72

28.07

umol/l

0.37

425

Other extrapyramidal and movement disorders in other diseases

380

1.72

4.15

1.2

1.5

24.65

23.61

umol/l

0.10

360

Other disorders of carbohydrate metabolism

8.32

4.10

5.4

1.7

13.89

12.74

umol/l

—

Other benign neoplasms of skin

609

1.55

4.09

1.3

1.5

24.42

22.45

umol/l

0.27

570

Other disorders of white blood cells

2.72

4.09

1.8

1.4

24.84

26.32

umol/l

0.07

Anterior Iridocyclitis

405

1.68

4.07

1.5

21.64

24.49

umol/l

0.34

385

Special screening examination for other diseases and disorders

104

2.41

4.05

1.6

1.2

24.59

23.82

umol/l

0.04

Other noninflammatory disorders of vagina

149

2.16

4.02

1.4

1.5

15.99

25.48

umol/l

1.67

141

TMD muscular pain linked with fibromyalgia

6.57

4.01

1.8

1.1

18.13

17.43

umol/l

—

Dental pulpitis 4, only avohilmo

355

1474

1.26

3.94

1.7

1.5

22.35

26.17

umol/l

1.60

331

1412

Acute generalized exanthematous pustulosis

2.73

3.92

1.7

1.4

14.67

27.44

umol/l

1.62

Unspecified/other endometriosis

191

2.00

3.92

1.7

1.5

24.42

26.10

umol/l

0.12

183

Lupus erythematosus

3.46

3.91

1.3

17.58

22.81

umol/l

0.31

Dental caries 1, only avohilmo

245

951

1.32

3.89

1.5

1.6

21.10

27.28

umol/l

2.67

233

909

Congenital absence, atresia and stenosis of small intestine

13.54

3.87

6.0

1.2

12.47

29.04

umol/l

—

Glucagon-like peptide-1 (GLP-1) analogues

127

722

1.45

3.86

1.3

1.4

16.48

25.81

umol/l

4.16

117

686

Melanocytic naevi

560

1.56

3.83

1.4

1.5

25.08

22.67

umol/l

0.31

527

Injuries to the head

347

1809

1.25

3.80

1.7

1.5

18.92

25.45

umol/l

5.04

324

1729

Defects in the complement system

5.79

3.69

2.9

1.2

29.62

17.31

umol/l

—

Maltreatment syndromes

109

2.31

3.69

1.7

1.5

28.71

27.06

umol/l

0.09

103

Other obstetric conditions, not elsewhere classified

137

626

1.42

3.68

1.4

1.5

25.04

25.26

umol/l

0.03

131

598

Injuries to the shoulder and upper arm

233

1504

1.30

3.65

1.4

1.5

19.30

25.47

umol/l

3.17

221

1428

Dental caries 3, only avohilmo

264

1052

1.28

3.50

1.5

1.6

20.48

27.62

umol/l

3.79

252

1006

273

1.72

3.45

1.4

1.3

22.68

22.46

umol/l

0.02

256

Other menopausal disorders

330

1.54

3.41

1.5

1.4

27.60

27.47

umol/l

0.01

311

Generalized skin eruption due to drugs and medicaments

2.68

3.40

1.8

1.4

15.12

27.57

umol/l

1.38

Other neurotic disorders

2.59

3.38

1.5

1.2

11.21

28.47

umol/l

4.01

Flatulence and related conditions

7.11

3.37

2.3

1.3

12.00

26.20

umol/l

—

Cerebrovascular diseases

177

949

1.34

3.35

1.5

1.4

18.12

25.74

umol/l

3.72

170

894

Injuries to the ankle and foot

224

1591

1.28

3.27

1.4

1.6

22.49

24.67

umol/l

0.56

213

1518

Dental pulpitis 1, only avohilmo

350

1486

1.23

3.27

1.6

1.5

22.27

26.10

umol/l

1.61

327

1423

Disorders of lipoprotein metabolism and other lipidaemias

205

986

1.31

3.27

1.4

19.79

27.41

umol/l

3.62

194

934

Follow-up examination after treatment for malignant neoplasms

2.34

3.24

1.2

1.3

17.59

27.21

umol/l

0.90

Disorders of choroid and retina

198

1103

1.31

3.24

1.5

1.4

20.77

25.38

umol/l

1.43

180

1051

Fracture of lower leg, including ankle

148

1088

1.36

3.23

1.5

24.44

25.77

umol/l

0.21

141

1030

Injury of nerves and spinal cord at thorax level

6.57

3.21

1.6

1.5

11.61

25.33

umol/l

—

Other retinal disorders

148

875

1.36

3.20

1.5

22.20

24.50

umol/l

0.42

135

835

Injuries to the neck

476

1.54

3.11

1.4

1.6

22.17

25.27

umol/l

0.39

454

Systemic disorders of connective tissue in diseases classified elsewhere

7.77

3.08

6.7

1.1

8.75

20.99

umol/l

—

Common variable immunodeficiency

5.14

3.08

5.4

1.2

9.20

17.07

umol/l

—

Benign paroxysmal vertigo

527

1.50

3.04

1.5

1.4

27.95

25.21

umol/l

0.29

499

Other congenital malformations of brain

4.45

3.04

1.8

1.9

12.16

15.99

umol/l

—

Artrosis, including avohilmo

248

1076

1.27

3.02

1.4

1.5

23.87

26.76

umol/l

0.74

236

1024

Extrapyramidal and movement disorders

617

1.46

3.02

1.2

1.5

26.60

23.89

umol/l

0.34

586

Disorders of lens

174

832

1.32

3.00

1.5

22.96

26.34

umol/l

0.74

165

784

Endometriosis ASRM stages 1,2

441

1.55

2.99

1.4

1.5

28.20

26.11

umol/l

0.20

421

Dental caries 2 and operation codes, only avohilmo

248

1223

1.26

2.98

1.6

26.84

21.62

umol/l

1.75

239

1159

Other secondary gonarthrosis

2.41

2.97

1.1

1.3

17.50

25.60

umol/l

0.64

Glucosamine medication

112

637

1.40

2.97

1.2

1.4

20.69

25.64

umol/l

1.13

105

597

Other crystal arthropathies

4.75

2.92

1.1

1.2

11.21

12.43

umol/l

—

Open wound of head

134

976

1.35

2.92

1.6

16.31

24.28

umol/l

4.30

126

932

Localized swelling, mass and lump of skin and subcutaneous tissue

589

1.46

2.92

1.4

1.5

22.37

23.69

umol/l

0.15

567

Monosomies and deletions from the autosomes, not elsewhere classified

7.04

2.91

4.7

2.1

12.10

11.06

umol/l

—

Moderate visual impairment, binocular

3.35

2.91

1.5

1.3

9.87

20.72

umol/l

—

DVT of lower extremities

288

1.67

2.90

2.1

1.3

21.59

24.49

umol/l

0.31

275

Other female pelvic inflammatory diseases

350

1.60

2.89

1.3

1.4

23.83

26.66

umol/l

0.27

331

Ischemic heart diseases

193

935

1.29

2.89

1.2

1.5

19.05

26.53

umol/l

3.49

176

886

Cicatricial alopecia [scarring hair loss]

5.50

2.88

1.0

1.1

21.29

18.37

umol/l

—

Inflammatory diseases of prostate (prostatitis)

136

1.99

2.84

1.4

1.6

25.45

26.08

umol/l

0.03

130

Crystal arthropathies, rheuma endpoint

4.49

2.80

1.1

1.4

11.21

25.16

umol/l

—

Marasmic kwashiorkor

8.78

2.79

3.4

1.5

10.06

13.38

umol/l

—

Congenital absence, atresia and stenosis of large intestine

6.60

2.78

6.5

3.3

14.27

13.20

umol/l

—

Nosocomial condition (hospital)

8.50

2.76

1.0

1.2

11.90

12.80

umol/l

—

Precocious central puberty

8.48

2.76

3.8

1.7

29.64

11.22

umol/l

—

Spinal osteochondrosis

5.06

2.74

2.0

1.0

24.46

13.00

umol/l

—

Visual impairment including blindness (binocular or monocular)

2.21

2.73

1.8

1.5

16.50

22.72

umol/l

0.51

Other benign neoplasms of skin

681

1.41

2.73

1.3

1.5

24.42

25.00

umol/l

0.07

646

Other and unspecified disorders of autonomic nervous system

6.21

2.72

1.5

1.2

50.00

12.60

umol/l

—

Acquired absence of limb

6.09

2.71

1.0

1.4

10.77

27.63

umol/l

—

Rheumatoid arthritis, including avohilmo

101

724

1.40

2.71

1.3

1.4

21.88

26.01

umol/l

0.75

685

Autoimmune hyperthyroidism

2.15

2.70

1.4

1.3

39.88

26.59

umol/l

0.77

Other and unspecified primary disorders of muscles

4.31

2.70

3.9

1.6

28.04

16.40

umol/l

—

Alcohol use disorder, Swedish definition

136

948

1.33

2.69

1.7

1.5

15.80

25.22

umol/l

5.62

131

900

Other noninflammatory disorders of uterus, except cervix

267

1.56

2.68

1.5

1.4

26.10

26.11

umol/l

0.00

250

Disorders of vitreous body

116

834

1.36

2.68

1.4

25.51

25.24

umol/l

0.03

107

784

Abnormalities of gait and mobility

175

1.83

2.67

1.8

1.5

15.45

22.74

umol/l

1.29

167

Other abnormal findings of blood chemistry

2.47

2.62

1.7

1.4

11.99

26.69

umol/l

2.93

Panniculitis, unspecified

4.73

2.61

1.3

1.1

23.00

17.45

umol/l

—

Ptosis of eyelid

155

1.88

2.60

1.3

1.4

19.88

23.16

umol/l

0.28

147

Intentional self-harm by unspecified means

4.72

2.60

1.0

1.1

33.07

18.05

umol/l

—

Other/unspecified enthesopathies of lower limb, excluding foot

127

1.98

2.60

1.7

1.4

19.28

24.03

umol/l

0.50

121

Lichen planopilaris

7.43

2.57

1.0

11.84

22.76

umol/l

—

Other or unspecified common variable immunodeficiency

5.68

2.57

5.2

1.3

8.93

12.14

umol/l

—

Congenital lens malformations

5.60

2.56

1.2

1.1

13.92

20.15

umol/l

—

Other prurigo

5.52

2.55

1.5

1.4

12.13

25.35

umol/l

—

Disorders of vitreous body and globe

118

858

1.34

2.50

1.4

25.26

25.37

umol/l

0.01

109

807

Abnormal blood-pressure reading, without diagnosis

2.33

2.48

2.3

1.4

36.93

23.03

umol/l

0.69

Other protozoal intestinal diseases

3.85

2.47

1.4

1.2

20.75

23.44

umol/l

—

Melanocytic naevi

619

1.41

2.47

1.4

1.5

25.08

24.94

umol/l

0.01

588

Parodontitis or/and operation codes

205

971

1.26

2.46

1.3

1.5

20.34

24.20

umol/l

1.23

190

926

Gonarthrosis,primary

221

1118

1.24

2.46

1.3

1.4

20.75

26.35

umol/l

2.19

209

1058

Fracture of shoulder and upper arm

678

1.39

2.45

1.4

1.6

19.40

24.13

umol/l

1.01

644

Traumatic subdural haemorrhage

114

1.99

2.44

1.3

15.20

25.64

umol/l

1.36

109

Respiratory insufficiency

2.14

2.43

1.3

1.6

18.36

22.96

umol/l

0.35

Other or unspecified immunodeficiency

5.18

2.43

1.7

42.38

19.18

umol/l

—

Other and unspecified disorders of binocular movement

5.11

2.42

1.0

2.0

25.08

19.73

umol/l

—

Salpingitis and oophoritis

383

1.52

2.42

1.7

1.4

16.54

28.28

umol/l

3.42

359

Artificial joint operation, meniscal resection

229

1236

1.23

2.40

1.4

21.81

25.91

umol/l

1.31

216

1169

Disorders of aromatic amino-acid metabolism

6.47

2.39

6.2

1.0

14.92

22.66

umol/l

—

Disorder of carbohydrate metabolism, other/unspecified

6.46

2.39

6.2

1.9

13.60

11.59

umol/l

—

Crossbite

196

1.71

2.38

2.7

2.0

18.99

20.84

umol/l

0.18

189

Thyrotoxicosis

525

1.43

2.35

1.4

34.35

24.81

umol/l

1.39

498

Effects of foreign body entering through natural orifice

492

1.45

2.34

1.3

1.6

24.94

24.22

umol/l

0.07

474

Fracture of neck

2.32

2.31

1.7

1.2

22.31

24.15

umol/l

0.07

Other fall from one level to another

485

1.45

2.31

1.7

13.90

23.27

umol/l

4.70

470

Benign neoplasm: Rectum

214

1.69

2.31

1.5

1.3

26.24

20.49

umol/l

0.48

201

Primary gonarthrosis, bilateral

111

726

1.34

2.31

1.4

16.96

26.85

umol/l

4.28

106

681

Pure hypercholesterolaemia

168

887

1.27

2.31

1.5

1.4

20.56

27.24

umol/l

2.38

159

840

Unknown and unspecified causes of morbidity

112

1.97

2.30

2.1

1.4

56.48

27.75

umol/l

2.24

107

Benign neoplasm: Rectum, anus and anal canal

245

1.64

2.30

1.5

1.3

28.63

21.25

umol/l

0.68

226

Deep bite

269

1.57

2.27

2.3

1.8

22.86

22.61

umol/l

0.02

257

Senile cataract

143

685

1.30

2.25

1.5

1.4

22.56

26.49

umol/l

0.81

136

643

Paracetamol of NSAID medication

212

1.50

2.23

1.9

1.6

29.28

24.57

umol/l

0.48

203

Hard cardiovascular diseases

191

984

1.25

2.22

1.4

1.5

17.15

25.90

umol/l

5.50

182

928

Scar conditions and fibrosis of skin

2.20

2.21

1.8

1.3

25.41

26.80

umol/l

0.06

Statin medication

229

1051

1.22

2.18

1.4

1.5

21.47

27.94

umol/l

2.81

218

1001

213

1.65

2.18

1.4

18.71

22.19

umol/l

0.36

202

Other benign neoplasms of connective and other soft tissue

173

1.74

2.16

1.3

1.4

27.31

22.18

umol/l

0.36

162

Postmenopausal bleeding

271

1.44

2.13

1.3

1.4

27.33

27.42

umol/l

0.01

254

Type 1 diabetes

535

1.40

2.13

1.7

24.69

25.07

umol/l

0.03

514

Other and unspecified disorders of vitreous body

686

1.35

2.10

1.4

1.3

28.33

25.18

umol/l

0.40

644

Propionic acid derivatives

345

1.37

2.10

1.5

1.8

28.40

22.88

umol/l

0.82

330

Meniscus derangement

138

736

1.28

2.09

1.4

1.5

22.41

28.40

umol/l

1.57

131

702

Infections with a predominantly sexual mode of transmission

742

1.34

2.08

1.3

1.5

26.65

25.29

umol/l

0.17

712

Impaction of intestines

5.08

2.08

3.6

1.4

11.72

27.26

umol/l

—

Fracture of forearm

152

1130

1.26

2.07

1.6

1.5

25.90

25.60

umol/l

0.04

144

1071

Single spontaneous delivery

652

0.74

2.06

1.4

1.6

20.54

24.24

umol/l

0.69

618

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

3.54

2.06

1.0

1.2

11.09

20.55

umol/l

—

Supervision of normal pregnancy

430

0.68

2.01

1.6

1.5

22.96

25.70

umol/l

0.29

414

Benign lipomatous neoplasm

483

1.41

2.01

1.3

1.4

20.24

23.27

umol/l

0.40

457

148

1053

1.26

2.01

1.7

1.5

16.31

25.63

umol/l

5.50

143

1003

Other disorders of the genitourinary system

217

1.62

1.96

2.3

1.4

19.13

23.75

umol/l

0.46

205

Transient ischemic attack

106

670

1.31

1.96

1.4

22.56

26.14

umol/l

0.58

100

633

Unspecified visual impairment (binocular)

2.99

1.94

2.4

1.9

26.05

18.26

umol/l

—

Viral hepatitis

136

1.77

1.87

2.5

1.6

17.90

27.77

umol/l

1.14

128

Respiratory distress of newborn

1.97

1.86

2.9

2.7

12.33

15.07

umol/l

1.23

Delivery

654

0.76

1.85

1.3

1.6

21.40

24.20

umol/l

0.47

620

Other symptoms and signs involving the urinary system

144

1.74

1.84

1.8

1.4

25.66

27.22

umol/l

0.09

137

Other benign neoplasms of connective and other soft tissue

182

1.65

1.84

1.3

1.5

27.31

25.14

umol/l

0.13

172

Other and unspecified aplastic anaemias

3.57

1.84

1.7

1.5

13.55

22.32

umol/l

—

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

117

622

1.29

1.83

1.3

1.4

23.71

22.74

umol/l

0.13

109

582

Leiomyosarcoma, excluding all cancers (controls excluding all cancers)

4.22

1.83

1.6

1.2

38.76

19.48

umol/l

—

Striking against or struck by other objects

707

1.32

1.82

1.7

1.6

22.76

23.84

umol/l

0.13

679

Specific development disorders of scholastic skills

121

1.81

1.82

2.4

1.9

30.79

23.52

umol/l

0.47

116

Ischaemic heart disease, wide definition

178

912

1.22

1.79

1.2

1.5

20.22

26.14

umol/l

2.04

161

868

Moderate mental retardation

3.39

1.76

2.3

1.2

13.60

12.60

umol/l

—

Chronic suppurative otitis media

124

1.78

1.75

1.5

1.4

15.85

24.66

umol/l

0.98

117

COPD-related respiratory insufficiency

132

1.75

1.73

1.2

1.4

13.48

24.84

umol/l

2.19

127

Onycholysis

3.91

1.72

3.2

1.1

12.38

18.22

umol/l

—

Pedal cyclist injured in collision with pedestrian or animal

3.90

1.72

1.0

1.2

28.88

12.30

umol/l

—

Other disorders originating in the perinatal period

2.33

1.72

3.6

2.3

13.96

13.08

umol/l

0.21

Other chondrocalcinosis

3.88

1.72

1.2

1.4

11.98

16.88

umol/l

—

Congenital malformations of heart and great arteries

328

1.45

1.72

1.9

14.65

21.55

umol/l

2.92

315

Intermittent heterotropia

148

1.70

2.2

1.8

15.17

23.79

umol/l

1.31

143

TMD related pain

2.01

1.70

1.2

1.4

15.57

25.13

umol/l

0.99

Other chromosome abnormalities, not elsewhere classified

3.24

1.68

2.3

3.1

12.10

11.26

umol/l

—

Bacterial sepsis of newborn

2.64

1.67

1.6

2.4

12.10

12.09

umol/l

—

Other congenital malformations, not elsewhere classified

3.20

1.67

1.5

1.4

13.73

19.31

umol/l

—

Nonpyogenic thrombosis of intracranial venous system

3.20

1.67

1.8

1.5

10.33

20.24

umol/l

—

Female infertility, associated with anovulation

172

1.63

1.67

1.5

18.11

27.60

umol/l

1.27

166

Migraine with aura, drug-induced

3.19

1.66

2.0

1.2

35.85

20.02

umol/l

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

640

1.31

1.66

1.5

1.6

20.44

25.19

umol/l

0.96

611

Injuries to the wrist and hand

289

1809

1.16

1.65

1.4

1.5

23.07

24.79

umol/l

0.47

271

1727

Other malignant neoplasms of skin (=non-melanoma skin cancer)

101

621

1.28

1.64

1.3

1.4

21.06

25.00

umol/l

0.72

584

Delivery, wide proxy

543

0.75

1.64

1.3

1.6

23.84

23.47

umol/l

0.04

516

Localized adiposity

3.64

1.62

1.6

1.3

11.76

28.16

umol/l

—

Hepatomegaly and splenomegaly, not elsewhere classified

3.61

1.62

1.6

1.4

33.02

22.45

umol/l

—

Sub-endpoint used in defining T1D endpoints

590

1.32

1.60

1.6

1.7

23.88

23.00

umol/l

0.09

566

Appendectomy

188

1520

1.19

1.59

1.6

1.5

24.86

25.44

umol/l

0.10

183

1440

Leiomyoma of uterus

193

919

1.20

1.57

1.3

1.4

28.22

26.31

umol/l

0.33

181

869

Fetus and newborn affected by maternal complications of pregnancy

0.00

1.54

0.0

2.3

—

13.76

—

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

1.93

1.54

1.7

1.4

14.61

26.53

umol/l

1.64

Hereditary deficiency of other clotting factors

3.37

1.53

5.8

1.1

11.66

24.17

umol/l

—

Atypical mycobacterium lung infection

3.36

1.53

1.8

1.3

12.04

15.75

umol/l

—

Disorders of orbit

1.91

1.49

1.3

1.5

39.23

27.01

umol/l

0.52

Other specified/unspecified soft tissue disorders

1.95

1.49

1.8

1.2

39.61

19.96

umol/l

1.03

Graves ophthalmopathy, strict

2.45

1.48

1.1

1.3

49.73

27.53

umol/l

—

Benign neoplasm: Rectum, anus and anal canal

276

1.45

1.46

1.5

1.4

28.63

24.30

umol/l

0.34

264

LSIL lesion of the vagina

2.52

1.45

1.3

1.2

12.57

24.66

umol/l

—

Other and unspecified vaccines and biological substances

3.17

1.44

1.2

2.3

45.78

21.87

umol/l

—

Acute lymphocytic leukaemia, helper endpoint

3.17

1.44

3.6

2.3

10.46

13.55

umol/l

—

Acute lymphocytic leukaemia, excluding all cancers (controls excluding all cancers)

3.17

1.44

3.6

2.3

10.46

13.55

umol/l

—

Injury of nerves at shoulder and upper arm level

3.15

1.44

1.8

1.4

10.46

20.95

umol/l

—

Drug-induced hypoglycaemia without coma

3.14

1.44

1.4

1.3

8.00

21.94

umol/l

—

Coxarthrosis

103

556

1.26

1.42

1.2

1.4

19.36

29.17

umol/l

3.10

534

Pustular psoriasis

1.86

1.40

1.1

1.5

16.06

24.77

umol/l

0.85

Viral infections of the central nervous system

134

1.65

1.39

1.8

1.5

27.27

26.09

umol/l

0.06

126

Endometriosis ASRM stages 3,4

545

1.30

1.38

1.5

1.4

23.44

26.18

umol/l

0.35

515

Birth trauma

2.65

1.37

1.0

2.7

29.42

13.06

umol/l

—

Acute lymphocytic leukaemia

2.98

1.36

3.6

1.9

10.46

16.93

umol/l

—

Other forms of systemic lupus erythematosus

2.97

1.36

1.0

1.1

10.78

22.41

umol/l

—

Other and unspecified bullous disorders

2.97

1.36

1.2

1.6

25.76

20.90

umol/l

—

Radial styloid tenosynovitis [de Quervain]

112

1.70

1.35

1.3

1.4

24.90

27.89

umol/l

0.15

105

Persons with potential health hazards related to communicable diseases

125

1022

1.21

1.34

2.0

1.6

23.80

23.93

umol/l

0.02

119

984

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

113

1.69

1.31

1.7

1.3

45.81

22.62

umol/l

1.70

106

Gonarthrosis, primary, with knee surgery

111

738

1.23

1.31

1.3

1.4

17.38

26.62

umol/l

3.38

105

693

Coronary atherosclerosis

138

739

1.20

1.30

1.3

1.5

17.97

26.14

umol/l

3.17

126

699

Intrahepatic Cholestasis of Pregnancy (ICP)

193

0.52

1.29

1.8

1.5

20.20

23.06

umol/l

—

184

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

511

1.25

1.28

1.3

23.20

22.00

umol/l

0.14

475

Coxarthrosis [arthrosis of hip](FG)

107

629

1.23

1.27

1.2

1.4

19.13

28.90

umol/l

3.28

101

597

conjunctival haemorrhage

1.72

1.27

1.3

1.4

24.50

23.93

umol/l

0.03

Persons encountering health services in circumstances related to reproduction

182

1054

1.17

1.26

1.7

1.6

25.80

24.66

umol/l

0.19

170

1013

Malignant neoplasm of breast, HER2-negative

845

0.81

1.24

1.3

1.4

37.96

25.64

umol/l

2.42

795

Pustulosis palmaris et plantaris

1.86

1.24

1.1

1.5

16.72

23.08

umol/l

0.48

Tubulo-interstitial nephritis, not specified as acute or chronic

100

1.70

1.23

2.6

1.2

15.21

27.11

umol/l

1.91

Malignant neoplasm of skin

118

733

1.21

1.23

1.3

1.4

21.85

25.19

umol/l

0.61

110

689

Other enthesopathies

565

1.28

1.22

1.5

24.86

26.47

umol/l

0.16

540

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

169

1178

1.17

1.22

1.5

1.4

25.89

26.31

umol/l

0.06

157

1128

Parkinson's disease, excluding more controls

113

1.64

1.20

1.1

1.3

31.40

27.27

umol/l

0.19

108

Other diseases of oesophagus

124

1.62

1.20

2.3

1.3

21.81

27.16

umol/l

0.39

117

Benign neoplasm: Rectum

255

1.41

1.19

1.5

1.4

26.24

23.98

umol/l

0.15

243

Disorders of continuity of bone

189

1.48

1.18

1.6

1.3

22.67

26.61

umol/l

0.28

178

Other viral hepatitis

117

1.63

1.18

2.5

1.6

15.61

29.97

umol/l

2.01

109

Phakomatoses, not elsewhere classified

2.52

1.15

1.6

1.2

26.50

16.72

umol/l

—

Pregnancy, childbirth and the puerperium

453

0.78

1.15

1.1

1.6

23.63

24.56

umol/l

0.09

432

Carcinoma in situ of skin of lower limb, including hip

2.51

1.15

1.4

24.84

21.81

umol/l

—

Malignant neoplasm of breast

861

0.82

1.15

1.3

1.4

38.95

25.47

umol/l

2.92

810

Other demyelinating diseases of the central nervous system

1.73

1.15

1.6

1.4

16.43

28.70

umol/l

1.39

Foreign body entering into or through eye or natural orifice

142

1.55

1.14

1.1

1.5

18.19

24.38

umol/l

0.64

135

Motorcycle rider injured in other and unspecified transport accidents

103

1.65

1.12

1.2

1.7

27.68

25.24

umol/l

0.10

Type 1 diabetes, wide definition, subgroup 1

439

1.30

1.12

1.8

1.6

21.35

25.08

umol/l

0.43

423

Benign lipomatous neoplasm

537

1.27

1.12

1.3

1.5

20.24

26.24

umol/l

1.02

513

Chronic suppurative otitis media, including avohilmo

159

1.51

1.11

1.5

1.7

18.28

23.48

umol/l

0.47

152

Vulvovaginal ulceration/inflammation in other diseases

144

1.53

1.08

2.1

1.6

14.71

24.72

umol/l

1.80

136

Sequelae of infectious and parasitic diseases

128

1.57

1.08

1.4

1.5

23.57

26.54

umol/l

0.17

122

Injury of muscle and tendon at shoulder and upper arm level

558

1.26

1.07

1.3

1.5

21.83

24.50

umol/l

0.34

535

Type 1 diabetes, wide definition

478

1.28

1.07

1.7

20.90

24.25

umol/l

0.41

458

Schizoaffective disorder

161

1.49

1.06

1.2

1.5

21.35

25.22

umol/l

0.30

151

Mixed connective tissue disease

129

1.55

1.05

1.3

1.5

19.55

24.18

umol/l

0.32

122

Undescended testicle

2.02

1.05

3.1

2.9

14.29

13.59

umol/l

—

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

508

1.22

1.05

1.3

22.61

22.06

umol/l

0.06

473

Basal cell carcinoma, including avohilmo

101

660

1.21

1.04

1.3

1.4

22.21

25.36

umol/l

0.50

619

Follicular cysts of skin and subcutaneous tissue

314

1.34

1.04

1.5

25.35

25.51

umol/l

0.01

297

Cardiovascular disorders originating in the perinatal period

2.31

1.04

2.8

2.3

11.56

12.20

umol/l

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

525

1.22

1.02

1.3

20.50

22.05

umol/l

0.21

487

Abnormal findings in secretions and smears from cervix uteri vagina vulva

155

1051

1.16

1.02

1.5

1.4

26.18

26.31

umol/l

0.02

144

1006

Other necrotizing vasculopathies

1.69

1.01

1.6

1.4

10.96

23.80

umol/l

3.61

Left bundle-branch block

1.69

1.01

1.4

1.3

17.95

27.96

umol/l

1.01

Outcome of delivery

337

0.75

1.00

1.4

1.5

30.43

26.46

umol/l

0.32

325

CR(E)ST syndrome

2.18

0.98

1.6

1.2

10.32

19.37

umol/l

—

Diabetic retinopathy, excluding more controls

277

1.26

0.94

1.6

18.35

20.97

umol/l

0.32

256

Injury of other and unspecified intrathoracic organs

1.65

0.94

1.4

25.41

24.85

umol/l

0.02

Tooth eruption problems

387

1.28

0.93

1.4

1.8

21.23

21.95

umol/l

0.07

371

Ménière disease

150

1.47

0.92

1.3

1.4

17.49

22.99

umol/l

0.49

141

Other specified congenital malformation syndromes affecting multiple systems

1.83

0.92

3.5

2.4

13.80

15.10

umol/l

—

Diabetic retinopathy

392

1.22

0.92

1.6

1.5

17.84

21.05

umol/l

0.49

367

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

126

1.51

0.91

2.3

1.4

23.52

24.37

umol/l

0.04

119

Sequelae of other and unspecified infectious and parasitic diseases

110

1.55

0.90

1.4

1.5

25.87

27.60

umol/l

0.08

105

Chronic viral hepatitis

1.60

0.90

2.2

1.6

10.51

31.49

umol/l

6.68

Basal cell carcinoma

643

1.19

0.90

1.3

1.4

21.91

25.41

umol/l

0.56

603

Postpartum haemorrhage due to anatomy

227

1.37

0.90

1.2

1.4

22.63

25.37

umol/l

0.22

219

Contact with machinery

143

1.47

0.89

1.5

18.81

24.27

umol/l

0.49

137

Other complications of labour and delivery, not elsewhere classified

299

0.71

0.85

1.3

1.6

25.33

24.52

umol/l

0.05

289

Anti-inflammatory and antirheumatic products, non-steroids

346

1.21

0.85

1.5

1.8

28.46

22.88

umol/l

0.76

331

Hodgkin lymphoma, hilmo

1.78

0.84

1.1

1.2

10.38

24.21

umol/l

—

Contraceptive management

123

747

1.16

0.84

1.4

1.5

27.06

umol/l

0.00

111

716

Impacted maxillary molar

137

1.46

0.84

1.6

1.5

26.19

26.44

umol/l

0.01

128

Angina pectoris

111

642

1.17

0.84

1.3

1.5

22.54

26.48

umol/l

0.68

100

609

Retinal detachments and breaks

533

1.22

0.83

1.6

1.4

22.88

26.22

umol/l

0.38

510

Major coronary heart disease event

135

784

1.15

0.82

1.3

1.5

16.80

25.00

umol/l

3.79

128

741

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

0.00

0.79

0.0

1.2

—

26.47

—

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

1.67

0.78

1.7

1.5

42.38

22.22

umol/l

0.92

Medical abortion

198

963

1.12

0.78

1.3

1.5

22.09

27.80

umol/l

2.02

183

913

Vasomotor rhinitis (mode)

131

1.45

0.78

1.6

1.4

16.47

26.06

umol/l

1.00

123

Varicose veins of other sites

100

0.50

0.77

1.6

1.4

58.64

25.85

umol/l

—

Unspecified lump in breast

331

1.27

0.77

1.2

1.5

32.13

25.88

umol/l

0.58

315

HSIL lesion of the cervix uteri, vagina or vulva

502

1.22

0.77

1.4

1.5

24.46

26.45

umol/l

0.21

481

Conductive hearing loss, unspecified

140

1.43

0.76

2.1

1.6

28.90

25.64

umol/l

0.17

130

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

2.01

0.73

1.0

1.6

12.80

12.62

umol/l

—

Pediculosis, acariasis and other infestations

1.52

0.72

1.7

1.4

24.23

25.20

umol/l

0.04

Exclusion endpoint for clefts

1.67

0.72

3.5

2.3

13.80

16.22

umol/l

—

Cardiac arrest

1.59

0.72

2.8

1.4

17.58

27.65

umol/l

0.76

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

159

0.63

0.72

1.8

1.5

20.20

25.15

umol/l

—

152

Abnormal findings on diagnostic imaging of central nervous system

1.58

0.71

4.3

1.4

31.44

29.10

umol/l

0.08

Septal defects

199

1.33

0.69

2.1

15.95

19.65

umol/l

0.57

191

Hallux valgus (acquired)

473

1.18

0.69

1.3

1.4

26.13

31.30

umol/l

0.65

451

Congenital malformations of eyelid, lacrimal apparatus and orbit

1.86

0.68

2.4

2.3

11.48

12.16

umol/l

—

Benign neoplasm: Descending colon

1.56

0.68

1.3

1.4

26.05

21.94

umol/l

0.16

Melanocytic naevi of other and unspecified parts of face

110

1.46

0.68

1.9

1.4

18.04

23.08

umol/l

0.33

103

Myocardial infarction

524

1.16

0.67

1.3

1.5

13.57

25.67

umol/l

6.64

499

Other congenital malformations

240

1.29

0.67

2.0

1.8

21.06

22.91

umol/l

0.16

231

Slow fetal growth and fetal malnutrition

1.79

0.66

2.0

2.8

11.86

12.28

umol/l

—

Abnormal findings on antenatal screening of mother

214

0.70

0.66

1.3

1.7

22.18

25.41

umol/l

0.17

200

Melanocytic naevi of other and unspecified parts of face

111

1.44

0.66

1.9

1.4

18.04

25.06

umol/l

0.49

105

Convergent concomitant strabismus

137

1.39

0.64

2.1

1.6

16.19

24.82

umol/l

1.03

130

Drug-induced neutropenia

120

1.42

0.64

1.5

1.4

23.99

23.92

umol/l

0.00

113

Other specific arthropathies, wide

1.73

0.64

1.2

1.3

39.02

26.61

umol/l

—

Acute lymphadenitis

121

1.41

0.62

1.2

1.5

11.13

26.41

umol/l

6.23

114

Parkinson's disease, including avohilmo

182

1.32

0.61

1.0

1.4

27.53

22.20

umol/l

0.35

173

Pregnancy with abortive outcome

205

978

1.10

0.61

1.3

1.5

22.11

27.57

umol/l

1.91

193

927

Other appendicitis

156

1.35

0.61

1.1

1.5

37.08

25.59

umol/l

0.76

147

Other congenital malformations of skull and face bones

0.00

0.60

0.0

2.7

—

11.56

—

Benign leiomyoma with endometriosis

289

1.25

0.60

1.3

1.4

37.28

24.31

umol/l

1.20

270

Contact with venomous snakes and lizards

0.00

0.60

0.0

1.3

—

19.14

—

Eustachian salpingitis and obstruction

174

1.32

0.60

1.7

1.6

29.84

24.31

umol/l

0.32

166

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

122

1.39

0.59

1.9

1.3

24.11

21.00

umol/l

0.17

116

Glaucoma

106

823

1.13

0.59

1.4

23.58

25.23

umol/l

0.22

101

773

Carcinoma in situ of breast, other/unspecified

0.00

0.59

0.0

1.1

—

20.22

—

Early lumbar disc prolapse, operated

201

1.30

0.58

1.8

1.5

19.95

23.83

umol/l

0.35

191

Later onset COPD, excluding more controls

156

1.30

0.58

1.2

1.4

13.33

22.13

umol/l

1.66

147

Carcinoma in situ of breast, other/unspecified

0.00

0.58

0.0

1.3

—

23.71

—

Open wound of wrist and hand

102

894

1.13

0.58

1.4

1.6

27.29

24.10

umol/l

0.46

855

Other mental disorders due to brain damage and dysfunction and to physical disease

149

1.34

0.57

1.7

1.3

12.45

22.65

umol/l

4.35

141

All dysplastic lesions of the cervix uteri, vagina or vulva

777

1.14

0.57

1.4

1.5

23.72

26.20

umol/l

0.37

747

Cramp and spasm

1.51

0.56

1.4

1.3

12.27

28.51

umol/l

3.85

Dental pulpitis 3

289

1.20

0.54

2.3

1.8

17.60

21.97

umol/l

0.71

282

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

694

0.88

0.54

1.5

1.4

36.23

24.49

umol/l

2.36

652

Polyhydramnios

125

0.64

0.54

1.6

30.20

22.20

umol/l

—

117

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

693

0.89

0.53

1.5

1.4

36.23

24.40

umol/l

2.39

651

Bacterial, viral and other infectious agents

169

1.30

0.53

1.7

1.5

22.47

25.08

umol/l

0.16

161

Spontaneous abortion

138

850

1.10

0.52

1.3

1.5

20.68

28.57

umol/l

2.88

130

805

Postpartum hemorraghe, parous women as controls

550

1.15

0.51

1.2

1.4

27.03

26.39

umol/l

0.06

531

Tobacco use

1.43

0.49

1.1

1.3

11.97

30.84

umol/l

5.10

Benign neoplasm of bone and articular cartilage

154

1.30

0.48

1.5

27.25

22.96

umol/l

0.24

145

Maternal care for known or suspected fetal abnormality and damage

403

0.84

0.47

1.4

1.6

29.49

25.96

umol/l

0.29

384

Vitreous haemorrhage

155

1.29

0.46

1.3

1.4

19.57

24.88

umol/l

0.40

148

Pedal cyclist injured in other and unspecified transport accidents

210

0.76

0.46

1.6

1.5

28.15

25.47

umol/l

0.15

200

Congenital malformations of the urinary system

130

1.31

0.44

1.7

1.6

20.38

22.73

umol/l

0.15

124

Foreign body or object entering through skin

104

1.35

0.43

1.1

1.6

16.15

28.22

umol/l

1.09

Coxarthrosis, primary

104

820

1.10

0.41

1.2

1.4

18.04

25.66

umol/l

2.42

769

Benign neoplasm of bone and articular cartilage

158

1.27

0.41

1.5

1.6

27.25

26.09

umol/l

0.06

150

Congenital malformations of larynx

0.00

0.41

0.0

1.9

—

12.05

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

1.36

0.41

1.5

1.2

28.32

17.92

umol/l

0.55

Melanoma in situ of lower limb, including hip

0.00

0.41

0.0

1.1

—

17.95

—

Atypical virus infections of central nervous system

0.00

0.41

0.0

1.4

—

22.26

—

Lower leg

0.00

0.41

0.0

1.3

—

17.05

—

Cellulitis of external ear

0.00

0.41

0.0

1.3

—

21.68

—

Preterm labour and delivery

661

1.12

0.41

1.3

1.5

27.24

26.72

umol/l

0.05

633

Nontoxic goitre/thyroid nodule

577

1.13

0.40

1.2

1.4

29.67

26.06

umol/l

0.37

541

Dysplastic lesion of unknown severity of the cervix uteri

0.00

0.40

0.0

1.1

—

26.98

—

Palatinal maxillary canine

0.00

0.39

0.0

2.4

—

17.18

—

Inflammatory disorders of breast

151

1.26

0.38

1.2

1.5

28.13

25.29

umol/l

0.15

143

Benign neoplasm of brain and other parts of central nervous system

116

0.69

0.37

1.6

1.4

11.40

21.75

umol/l

—

108

Intracerebral haemorrhage

152

1.25

0.36

1.4

21.08

22.86

umol/l

0.10

146

Injury of unspecified body region

135

0.74

0.36

3.3

1.5

34.50

24.92

umol/l

—

127

Congenital malformations of eye, ear, face and neck

171

1.23

0.35

1.5

1.7

24.73

23.78

umol/l

0.05

161

Persistent delusional disorders

117

1.28

0.35

1.3

1.4

23.81

23.86

umol/l

0.00

109

Other maternal disorders predominantly related to pregnancy

178

1049

1.07

0.35

1.4

1.5

24.58

27.00

umol/l

0.50

167

994

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

0.69

0.33

4.3

2.8

14.82

14.81

umol/l

—

Use of levodopa decarboxylase inhibitor

155

0.77

0.33

1.0

1.4

23.66

19.78

umol/l

0.17

147

Sarcoidosis

238

1.18

0.32

1.7

1.3

40.89

24.28

umol/l

1.40

226

Aneurysms, operations, SAH

266

1.17

0.32

1.3

1.4

22.68

24.06

umol/l

0.10

251

Major coronary heart disease event excluding revascularizations

110

703

1.08

0.31

1.3

1.5

16.39

24.88

umol/l

3.42

103

665

Benign neoplasm: Long bones of lower limb

1.32

0.31

1.7

1.4

23.18

31.54

umol/l

—

Other disorders of conjunctiva

221

1.18

0.30

1.3

22.98

24.26

umol/l

0.08

211

Complications predominantly related to the puerperium

673

0.91

0.30

1.3

1.5

24.60

26.90

umol/l

0.24

646

Acute nasopharyngitis (common cold)

206

0.82

0.30

2.4

1.7

21.71

26.83

umol/l

0.33

197

Prolonged pregnancy

412

0.89

0.29

1.4

1.6

22.17

26.22

umol/l

0.48

391

Complications of the puerperium, not elsewhere classified

107

0.75

0.29

1.3

1.4

23.25

26.23

umol/l

—

101

L02BA Anti-estrogens

345

0.87

0.29

1.5

1.4

39.01

25.40

umol/l

1.20

328

Malignant neoplasm of head and neck

1.28

0.28

2.3

1.3

24.10

27.19

umol/l

0.13

Cluster headache, strict, including avohilmo

1.26

0.26

1.5

1.4

12.06

27.32

umol/l

4.74

Burn and corrosion of wrist and hand

1.23

0.25

2.1

1.6

11.79

26.80

umol/l

—

Other diseases of peritoneum

1.23

0.25

1.8

1.3

12.08

27.55

umol/l

—

Toxic effect of ethanol

1.22

0.25

3.3

1.4

10.89

25.49

umol/l

—

Other diseases of blood and blood-forming organs

105

1.24

0.24

2.5

1.3

12.80

26.59

umol/l

4.11

100

Other peripheral vascular diseases

142

1.20

0.24

1.5

1.4

26.56

25.55

umol/l

0.04

134

Cyst of Bartholin Gland

0.70

0.24

1.2

1.4

52.74

24.85

umol/l

—

Benign leiomyoma with endometriosis

322

1.12

0.23

1.3

1.4

37.28

25.47

umol/l

1.05

306

Nontraumatic intracranial haemmorrhage

275

1.13

0.23

1.3

1.4

19.75

23.68

umol/l

0.38

262

Haemangioma, any site

168

0.83

0.22

1.3

1.6

51.22

23.83

umol/l

1.50

161

Melanocytic naevi of lower limb, including hip

1.27

0.22

1.3

26.32

23.18

umol/l

—

Fetus and newborn affected by noxious influences transmitted via placenta or breast milk

0.00

0.22

0.0

2.7

—

11.27

—

Changes in corneal membranes

0.00

0.21

0.0

1.0

—

19.90

—

Benign neoplasm: Female genital organ, unspecified

0.00

0.21

0.0

1.0

—

19.98

—

Cleft lip

0.00

0.21

0.0

1.1

—

12.37

—

Maternal care for (suspected) damage to fetus from alcohol

0.00

0.21

0.0

1.1

—

38.72

—

Congenital malformations of ear causing impairment of hearing

0.00

0.21

0.0

1.0

—

20.07

—

Moderate visual impairment, monocular

0.00

0.21

0.0

1.1

—

19.12

—

Chronic myeloid leukaemia

0.00

0.21

0.0

1.2

—

20.84

—

Findings of drugs and other substances, not normally found in blood

0.00

0.21

0.0

1.3

—

25.41

—

Benign neoplasm: Eye, unspecified

0.00

0.21

0.0

1.1

—

20.42

—

Malignant neoplasm of gallbladder

0.00

0.21

0.0

1.1

—

12.78

—

Necrotizing fasciitis

0.00

0.21

0.0

1.0

—

11.22

—

Carcinoma in situ of breast

0.00

0.21

0.0

1.1

—

18.57

—

Other infiltrative disorders of skin and subcutaneous tissue

0.00

0.21

0.0

1.0

—

19.01

—

Colour vision deficiencies

0.00

0.21

0.0

1.1

—

11.52

—

Familial erythrocytosis

0.00

0.21

0.0

1.0

—

20.83

—

Right side

0.00

0.21

0.0

1.4

—

26.38

—

Thiamine deficiency

0.00

0.21

0.0

1.2

—

20.74

—

Discontinuity and dislocation of ear ossicles

0.00

0.21

0.0

1.6

—

26.78

—

Melanoma in situ of lower limb, including hip

0.00

0.21

0.0

1.2

—

22.74

—

Toxic effect of other gases, fumes and vapours

0.00

0.21

0.0

1.1

—

12.45

—

Wilms' tumor

0.00

0.21

0.0

2.0

—

17.92

—

Contact with hot air and gases

0.00

0.21

0.0

1.6

—

19.52

—

Degenerative myopia

0.00

0.21

0.0

1.4

—

25.65

—

Use of entacapone

0.00

0.21

0.0

1.3

—

25.53

—

Lesion of medial popliteal nerve

0.00

0.21

0.0

1.2

—

19.33

—

Carcinoma in situ of endometrium

0.00

0.21

0.0

1.1

—

18.61

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

0.00

0.21

0.0

1.3

—

13.16

—

Felty syndrome

0.00

0.21

0.0

1.1

—

18.85

—

Malignant neoplasm of nasal cavity and sinuses

0.00

0.21

0.0

1.4

—

24.22

—

Injury of blood vessels at wrist and hand level

0.00

0.21

0.0

1.4

—

22.98

—

Benign neoplasm of brain and other parts of central nervous system

104

0.77

0.21

1.6

1.4

11.40

23.95

umol/l

—

Mucinous and mucinous cystic tumor

0.00

0.21

0.0

1.1

—

18.18

—

Cholinergic urticaria

0.00

0.21

0.0

1.4

—

23.58

—

Malignant neoplasm of other and unspecified parts of mouth

0.00

0.21

0.0

1.3

—

22.82

—

Maxillary prognathism

0.00

0.21

0.0

2.3

—

12.42

—

Hyperprolactinaemia, drug-induced

0.00

0.21

0.0

1.1

—

24.92

—

Contact with blunt object, undetermined intent

0.00

0.21

0.0

1.8

—

23.25

—

Lesion of femoral nerve

0.00

0.21

0.0

1.2

—

18.14

—

Meningococcal infection

0.00

0.21

0.0

1.3

—

24.04

—

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

306

1.11

0.20

1.4

1.3

59.70

21.78

umol/l

5.26

287

Complications of labour and delivery

176

1024

0.96

0.20

1.2

1.5

29.52

25.79

umol/l

0.78

158

976

Other benign neoplasms of uterus

1.25

0.20

2.1

1.3

18.53

20.92

umol/l

—

Carcinoma in situ of uteri, other/unspecified

0.00

0.20

0.0

1.1

—

17.66

—

Blindness, monocular

0.00

0.20

0.0

1.1

—

18.09

—

Pedestrian injured in transport accident

112

0.80

0.20

1.1

1.3

21.62

26.49

umol/l

—

105

Appendicitis, broad definition

186

1637

1.04

0.19

1.5

25.10

25.54

umol/l

0.07

179

1555

Diseases of appendix

187

1641

1.04

0.18

1.5

25.08

25.51

umol/l

0.07

180

1559

Early lumbar disc prolapse operation

242

1.12

0.18

1.8

1.5

19.65

25.88

umol/l

0.67

229

Abnormalities of forces of labour

288

0.90

0.16

1.4

1.6

22.89

25.19

umol/l

0.18

279

Left ventricular outflow tract obstruction (LVOTO), broad definition

183

0.87

0.16

1.1

1.6

23.07

23.08

umol/l

0.00

175

Cluster headache, wide,, including avohilmo

102

1.18

0.15

1.5

1.4

12.06

27.45

umol/l

5.08

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

150

1.13

0.14

1.6

1.3

29.62

22.81

umol/l

0.36

137

Normotensive glaucoma

112

1.16

0.14

1.2

1.3

30.05

19.36

umol/l

0.50

104

Maternal care for other known or suspected fetal problems

495

1.05

0.14

1.3

1.6

24.65

25.45

umol/l

0.09

473

Melanocytic naevi of lower limb, including hip

1.19

0.14

1.3

26.32

24.94

umol/l

—

Chalazion

218

1.10

0.13

1.2

1.5

21.85

24.68

umol/l

0.19

207

Dental caries 3 and operation codes, only avohilmo

102

534

0.96

0.13

1.6

1.7

20.79

24.91

umol/l

0.82

510

Other osteochondropathies

132

1.14

0.13

1.7

1.3

15.99

26.81

umol/l

1.14

124

Later onset COPD

223

0.92

0.13

1.2

1.3

13.33

20.31

umol/l

1.32

209

Other congenital malformations of skin

1.17

0.13

1.0

1.6

29.58

25.35

umol/l

0.16

Otosclerosis

133

1.13

0.12

1.0

1.4

21.07

23.40

umol/l

0.12

125

Superficial injury of shoulder and upper arm

201

1.09

0.11

1.7

1.5

17.37

24.88

umol/l

0.93

192

Haemangioma, any site

157

0.89

0.11

1.3

1.6

51.22

22.09

umol/l

1.63

149

Malignant neoplasm of corpus uteri

125

0.88

0.10

1.8

1.3

33.24

20.37

umol/l

0.54

120

Benign neoplasm: Adrenal gland

106

1.13

0.09

1.2

1.4

17.69

20.59

umol/l

0.19

100

Conotruncal defects

1.03

0.08

1.0

2.4

12.88

14.46

umol/l

—

Benign neoplasm: Skin, unspecified

1.03

0.08

1.0

1.3

19.77

25.83

umol/l

—

Haemangioma and lymphangioma, any site

185

0.92

0.08

1.4

1.6

44.69

23.33

umol/l

1.32

177

Male infertility

1.06

0.08

2.0

1.5

23.67

32.57

umol/l

—

Benign neoplasm: Adrenal gland

108

1.11

0.07

1.2

1.4

17.69

22.67

umol/l

0.36

101

Other noninflammatory disorders of cervix uteri

1.05

0.07

1.3

1.4

20.24

24.46

umol/l

—

Myeloproliferative diseases (CML excluded)

104

0.86

0.06

1.2

1.3

12.73

23.26

umol/l

—

Endovascular or surgical operations to intracerebral aneurysms

105

0.86

0.06

1.1

1.4

18.98

24.67

umol/l

—

100

Myeloproliferative diseases

121

0.91

0.06

1.2

1.3

20.39

24.28

umol/l

0.19

115

Contact with and exposure to communicable diseases

876

0.98

0.05

2.0

1.6

24.91

24.27

umol/l

0.07

843

Lesion of plantar nerve

110

0.91

0.05

1.8

1.4

25.68

24.30

umol/l

—

103

Embedded teeth, including avohilmo

232

0.95

0.05

1.1

1.6

21.85

25.39

umol/l

0.28

219

Parkinson's disease

179

1.06

0.04

1.1

1.4

31.40

21.87

umol/l

0.57

170

Postpartum haemorrhage

639

0.98

0.03

1.2

1.6

27.03

26.22

umol/l

0.08

618

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

220

1.05

0.03

1.8

1.5

20.81

25.50

umol/l

0.40

209

Acute appendicitis

170

1587

1.01

0.03

1.5

24.08

25.60

umol/l

0.28

163

1508

Aortic valve malfunction, age under 60 years

149

0.94

0.03

1.1

1.4

24.29

23.98

umol/l

0.01

142

Obstructed labour due to malposition and malpresentation of fetus

615

0.98

0.03

1.4

1.5

29.35

26.14

umol/l

0.34

594

Other puerperal infections

199

0.95

0.03

1.5

1.4

15.23

24.82

umol/l

1.49

191

Coxarthrosis, primary, with hip surgery

652

1.02

0.03

1.3

1.4

17.49

25.62

umol/l

2.06

615

Other spirochaetal diseases

500

1.02

0.02

1.3

1.5

37.41

26.00

umol/l

1.19

475

Maternal care related to the fetus and amniotic cavity and possible delivery problems

140

816

1.01

0.02

1.3

1.5

30.93

25.57

umol/l

1.12

132

780

Postpartum hemorraghe, all women as controls

706

1.02

0.02

1.2

1.5

27.03

26.39

umol/l

0.06

679

Divergent concomitant strabismus

158

0.95

0.02

1.5

16.67

24.63

umol/l

0.76

150

Parkinson's disease, strict definition

162

1.05

0.02

1.0

1.3

33.59

21.51

umol/l

0.68

153

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

128

1110

1.01

0.02

1.5

1.4

24.88

26.83

umol/l

0.31

122

1053

False labour

610

1.01

0.01

1.3

1.6

29.60

25.08

umol/l

0.69

584

Retained placenta and membranes, without haemorrhage

297

0.98

0.01

1.3

1.5

29.62

24.76

umol/l

0.33

286

Etanercept

144

1.04

0.00

1.4

1.5

20.06

25.46

umol/l

0.36

136

Inguinal hernia

110

737

1.01

0.00

1.5

21.20

23.94

umol/l

0.48

102

701

Nontoxic multinodular goitre

326

0.98

0.00

1.1

1.5

26.67

24.78

umol/l

0.12

305

Thoracic aortic aneurysm

152

0.99

0.00

2.4

1.4

19.86

25.35

umol/l

0.35

147

Cardiomyopathy, other and unspecified

105

1.05

0.00

1.5

1.3

23.92

27.29

umol/l

0.15

Placenta praevia

125

1.04

0.00

1.9

1.6

44.80

22.80

umol/l

1.22

119

Subarachnoid haemorrhage

156

1.03

0.00

1.1

1.5

21.46

21.37

umol/l

0.00

148

Lyme disease

492

1.00

0.00

1.2

1.5

38.49

25.83

umol/l

1.31

468

Myocardial infarction, with ST-elevation

191

0.99

0.00

1.2

1.3

10.44

24.67

umol/l

8.23

185

Haemangioma and lymphangioma, any site

169

1.01

0.00

1.4

1.6

44.69

21.87

umol/l

1.44

160

Tooth agenesis EXCLUDE clefts and syndromes

105

0.95

0.00

2.4

1.9

12.00

22.27

umol/l

—

Malignant neoplasm of nasal cavity and middle ear

0.00

0.0

1.5

—

24.28

—

Abnormality of red blood cells

0.00

0.0

1.3

—

27.63

—

Burn and corrosion of other internal organs

0.00

0.0

1.4

—

12.38

—

Indeterminate sex and pseudohermaphroditism

0.00

0.0

1.0

—

12.06

—

Other effects of reduced temperature

0.00

0.0

1.6

—

18.54

—

Drowning and submersion while in natural water

0.00

0.0

2.2

—

11.52

—

Congenital malformations of lung

0.00

0.0

3.0

—

22.64

—

Unspecified transport accident

0.00

0.0

1.1

—

21.92

—

Eclampsia

0.00

0.0

1.2

—

27.50

—

Rapidly progressive nephritic syndrome

0.00

0.0

1.7

—

23.35

—

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

0.00

0.0

1.3

—

27.90

—

Hyperfunction of pituitary gland, other and/or unspecified

0.00

0.0

1.2

—

14.08

—

Benign neoplasm: Endocrine gland, other/unspecified

0.00

0.0

1.0

—

10.63

—

Malignant neoplasm of renal pelvis, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.1

—

13.36

—

Pupillary membranes and other adhesions and disruptions of iris and ciliary body

0.00

0.0

1.4

—

12.06

—

Dysplastic lesion of the vulva of unknown severity

0.00

0.0

1.0

—

25.45

—

Disease of thymus, other/unspecified

0.00

0.0

1.2

—

13.58

—

Qualitative platelet defects

0.00

0.0

1.0

—

11.78

—

Myocarditis

0.91

0.00

1.8

1.2

11.45

28.62

umol/l

—

Benign neoplasm: Thymus

0.00

0.0

1.1

—

12.11

—

Benign neoplasm: Ciliary body

0.00

0.0

1.0

—

12.54

—

Cytomegaloviral pneumonitis

0.00

0.0

1.0

—

11.78

—

Malignant neoplasm of palate, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.1

—

13.13

—

Other cestode infections

0.00

0.0

1.0

—

12.25

—

Carcinoma in situ of middle ear and respiratory system

0.00

0.0

1.4

—

19.68

—

Cerebral aneurysm, nonruptured

150

1.00

0.00

1.6

1.4

24.07

25.51

umol/l

0.06

141

Benign neoplasm: Ribs, sternum and clavicle

0.00

0.0

1.4

—

21.43

—

Monocytic leukaemia

0.00

0.0

1.1

—

13.77

—

Malignant neoplasm of other and unspecified urinary organs, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.1

—

12.79

—

Immunodeficiency associated with other major defects

0.00

0.0

1.3

—

12.79

—

Melanoma in situ, other sites/unspecified

0.00

0.0

1.1

—

20.34

—

Hereditary spherocytosis

0.00

0.0

1.5

—

11.62

—

Drug-induced dystonia

0.00

0.0

1.2

—

12.10

—

Chondrosarcoma, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.4

—

25.13

—

Toxic colitis

0.00

0.0

1.3

—

19.83

—

Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced

0.00

0.0

1.6

—

20.74

—

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

0.00

0.0

1.2

—

27.92

—

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

12.88

—

Secondary sideroblastic anaemia

0.00

0.0

1.0

—

13.04

—

Sickle-cell disorders

0.00

0.0

1.0

—

23.84

—

Dislocation, sprain and strain of joints and ligaments of head

1.01

0.00

1.9

1.5

14.54

26.14

umol/l

—

Drug-induced gout

0.00

0.0

1.5

—

22.72

—

Medullary carcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

12.60

—

Malignant neoplasm of nasal cavity and sinuses, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.1

—

13.90

—

Postinfectious hypothyroidism

0.00

0.0

1.4

—

19.91

—

Wilms' tumor, excluding all cancers (controls excluding all cancers)

0.00

0.0

2.0

—

12.27

—

Malignant neoplasm of meninges, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

13.33

—

Sequelae of hyperalimentation

0.00

0.0

1.0

—

24.58

—

Lipomatosis, not elsewhere classified

0.00

0.0

1.2

—

26.10

—

Deficiency of other/unspecified vitamins

0.00

0.0

1.0

—

11.06

—

Disorders of purine and pyrimidine metabolism

0.00

0.0

1.3

—

27.90

—

Epileptic seizures related to drugs

0.00

0.0

1.2

—

13.30

—

Other endophthalmitis

0.00

0.0

1.1

—

21.57

—

Other congenital malformations of posterior segment of eye (coloboma)

0.00

0.0

1.2

—

11.48

—

Acute thyroiditis

0.00

0.0

1.1

—

12.90

—

Drug-induced myopathy

0.00

0.0

1.6

—

22.06

—

Mental and behavioural disorders due to hallucinogens

0.00

0.0

1.0

—

13.38

—

Ankylosis of joint

0.00

0.0

1.1

—

12.00

—

Disorders of glossopharyngeal nerve

0.00

0.0

1.0

—

13.30

—

Acute disseminated encephalitis/encephalomyelitis

0.00

0.0

1.0

—

23.75

—

Food allergy

0.00

0.0

1.8

—

22.17

—

Other cranial nerve disorders in other disorders

0.00

0.0

1.2

—

13.52

—

Malignant neoplasm of nasal cavity and middle ear, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

13.82

—

Glaucoma secondary to drugs

0.00

0.0

1.4

—

33.37

—

Abnormalities of ear ossicles

0.00

0.0

1.3

—

22.66

—

Cytomegaloviral hepatitis

0.00

0.0

1.1

—

21.25

—

Degenerative conditions of globe

0.00

0.0

1.4

—

12.98

—

Mantle cell lymphoma

0.00

0.0

1.3

—

27.64

—

Other specified/unspecified diseases of inner ear

0.00

0.0

1.0

—

12.73

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system

0.00

0.0

1.0

—

14.00

—

Other specified/unspecified disorders of middle ear and mastoid

0.00

0.0

1.1

—

21.03

—

Malignant neoplasm of accessory sinuses, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

14.05

—

Tympanosclerosis

0.00

0.0

1.0

—

25.68

—

Airway disease due to specific organic dust

0.00

0.0

1.0

—

11.85

—

Hypertensive encephalopathy

0.00

0.0

1.0

—

11.62

—

Liver disorders in diseases classified elsewhere

0.00

0.0

1.2

—

24.37

—

Unspecified multiple injuries

0.00

0.0

1.1

—

11.24

—

Relapsing polychondritis

0.00

0.0

1.0

—

22.23

—

Ependymoma

0.00

0.0

1.0

—

13.28

—

Traumatic amputation of shoulder and upper arm

0.00

0.0

1.6

—

24.70

—

Mucinous and mucinous cystic tumor of rectum

0.00

0.0

1.7

—

23.73

—

Other and unspecified water transport accidents

0.00

0.0

1.0

—

25.29

—

Monocytic leukaemia

0.00

0.0

1.0

—

14.48

—

Malignant neoplasm of thymus

0.00

0.0

1.1

—

11.17

—

Oesophagitis, drug-induced

0.00

0.0

1.0

—

12.22

—

Malignant neoplasm of renal pelvis

0.00

0.0

1.5

—

22.38

—

Malignant neoplasm of floor of mouth

0.00

0.0

1.0

—

13.08

—

Injury of heart

0.00

0.0

1.0

—

11.58

—

Malignant neoplasm of palate

0.00

0.0

1.0

—

11.94

—

Malignant neoplasm of other and unspecified major salivary glands

0.00

0.0

1.0

—

11.07

—

Malignant neoplasm of gum

0.00

0.0

1.4

—

19.20

—

Ependymoma, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

13.28

—

Acrodermatitis chronica atrophicans

0.00

0.0

1.0

—

12.22

—

Contact with sharp glass

0.95

0.00

1.4

30.99

28.03

umol/l

—

Poikiloderma of Civatte

0.00

0.0

1.1

—

12.13

—

Café au lait spots

0.00

0.0

2.3

—

11.12

—

Malignant neoplasm of other endocrine glands and related structures

0.00

0.0

1.2

—

9.78

—

Other and unspecified localized connective tissue disorders

0.00

0.0

1.0

—

21.09

—

Injury of blood vessels at forearm level

0.00

0.0

1.2

—

13.25

—

Malignant neoplasm of accessory sinuses

0.00

0.0

1.3

—

12.33

—

Other hypertrichosis

0.00

0.0

1.0

—

41.32

—

Other specific arthropathies

0.00

0.0

1.2

—

11.93

—

Acquired atrophy of ovary and fallopian tube

0.00

0.0

1.0

—

29.70

—

Abnormal findings in bronchial washings nasal secretions pleural fluid sputum throat scrapings

0.00

0.0

1.2

—

13.10

—

Fatigue fracture of vertebra

0.00

0.0

1.0

—

12.13

—

Other infective (teno)synovitis

0.00

0.0

1.1

—

22.00

—

Alcoholic cardiomyopathy

0.00

0.0

1.8

—

26.10

—

Benign neoplasm: Lacrimal gland and duct

0.00

0.0

1.0

—

11.68

—

Disorders of muscle in diseases classified elsewhere

0.00

0.0

1.0

—

13.57

—

Complications following myocardial infarction

0.00

0.0

1.0

—

23.19

—

Chondrosarcoma

0.00

0.0

1.6

—

25.14

—

Benign neoplasm: Testis

0.00

0.0

1.8

—

25.68

—

Nephropathy induced by other drugs, medicaments and biological substances

0.00

0.0

1.2

—

12.90

—

Other and unspecified heterotropia

0.00

0.0

1.1

—

22.14

—

Craniosynostosis EXCLUDE syndromes

0.00

0.0

1.9

—

11.07

—

Oher contracture of tendon (sheath)

0.00

0.0

1.2

—

26.32

—

Hypospadias

0.00

0.0

4.4

—

13.04

—

Glycosuria

0.00

0.0

1.2

—

11.90

—

Calcinosis cutis

0.00

0.0

1.0

—

12.88

—

Henoch-Schönlein purpura nephritis (HSPN)

0.00

0.0

1.2

—

24.57

—

Need for immunization against certain single viral diseases

0.00

0.0

1.2

—

12.90

—

Obstetric embolism

0.00

0.0

1.0

—

29.88

—

Fetus and newborn affected by complications of placenta, cord and membranes

0.00

0.0

1.1

—

10.94

—

Melanoma in situ, other sites/unspecified

0.00

0.0

1.0

—

12.56

—

Carcinoma in situ of breast

0.00

0.0

1.2

—

12.07

—

Chronic thyroiditis

0.00

0.0

1.0

—

11.06

—

Carcinoma in situ of uteri, other/unspecified

0.00

0.0

1.0

—

13.34

—

Maze procedure for atrial fibrillation

0.00

0.0

1.5

—

19.72

—

Complications of anaesthesia during the puerperium

0.00

0.0

1.1

—

13.65

—

Benign neoplasm: Thymus

0.00

0.0

1.0

—

12.28

—

Benign lipomatous neoplasm of intrathoracic organs

0.00

0.0

1.0

—

14.60

—

Benign neoplasm: Female genital organ, unspecified

0.00

0.0

1.0

—

13.68

—

0.00

0.0

1.2

—

12.56

—

Left side

0.00

0.0

1.7

—

22.45

—

0.00

0.0

1.3

—

22.99

—

Use of pergolide

0.00

0.0

1.0

—

10.68

—

Family history of mental and behavioural disorders

0.00

0.0

1.3

—

25.50

—

Choroidal haemorrhage and rupture

0.00

0.0

1.7

—

22.98

—

Tick-borne viral encephalitis

0.00

0.0

1.3

—

12.41

—

Other infestations

0.00

0.0

1.2

—

13.20

—

Pedestrian injured in collision with other nonmotor vehicle

0.00

0.0

1.0

—

12.33

—

Foreign object accidentally left in body during surgical and medical care

0.00

0.0

1.0

—

13.50

—

Rifle, shotgun and larger firearm discharge

0.00

0.0

1.0

—

12.92

—

Intentional self-harm by jumping or lying before moving object

0.00

0.0

1.2

—

12.26

—

Injury of blood vessels at shoulder and upper arm level

0.00

0.0

1.0

—

26.94

—

Dengue fever [classical dengue]

0.00

0.0

1.3

—

13.58

—

Accidental poisoning by and exposure to pesticides

0.00

0.0

1.7

—

35.42

—

Use of biperiden

1.00

0.00

1.0

1.3

22.25

26.42

umol/l

—

Toxic effect of other noxious substances eaten as food

0.00

0.0

1.2

—

11.85

—

Open wounds involving multiple body regions

0.00

0.0

1.4

—

27.94

—

Diphtheria

0.00

0.0

2.0

—

22.91

—

Osteochondrodysplasia with defects of growth of tubular bones and spine

0.00

0.0

2.4

—

13.72

—

Other injuries involving multiple body regions, not elsewhere classified

0.00

0.0

1.6

—

22.71

—

Other congenital malformations of eye

0.00

0.0

1.2

—

11.20

—

Contusion of other and unspecified parts of foot

110

1.00

0.00

2.5

1.6

18.72

25.41

umol/l

0.41

105

Malignant neoplasm of other and unspecified urinary organs

0.00

0.0

1.0

—

11.34

—

Benign lipomatous neoplasm of intrathoracic organs

0.00

0.0

1.0

—

13.30

—

Carcinoma in situ of endometrium

0.00

0.0

1.3

—

23.61

—

Toxic erythema

0.00

-0.00

0.0

1.2

—

29.80

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Zinc [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS